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“Is	anybody	listening,	tell	me	can	you	see	
This	darkness	surrounding	me	
Now	it's	getting	colder,	heavy	on	my	shoulder	
And	it's	getting	hard	to	breathe	
Vision’s	getting	blurry,	I'm	getting	worried	
Cause	it's	getting	hard	to	see	
When	you're	living	in	the	house	of	pain”	Living	in	pain:	Notorious	B.I.G	feat.	2Pac,	Mary	J	Blige	&	Nas	
  
  
 
 
  
ABSTRACT 
Background: Pediatric chronic pain is prevalent, affecting between 11-38% of children and 
adolescents, with a subset of individuals suffering from substantial pain-related disability. 
Dysfunction in emotional, social and physical domains, as well as parental distress, 
commonly co-occurs with pediatric chronic pain. The effectiveness of behavior oriented 
treatments for child pain intensity and disability is today well known, but there is still a need 
for further development of such treatments, including evaluations of different treatment 
formats and parent support programs. There is also a need to further develop and evaluate 
instruments to assess pain-related dysfunction in pediatric chronic pain.  
Purpose and aims: The purpose of this doctoral project was to develop effective ways to 
assess and treat dysfunction in pediatric chronic pain. The aims were to 1) evaluate the 
psychometric properties of the Insomnia Severity Index (ISI) for youths (study I) and the 
psychometric properties of the Pain Interference Index (PII) (study II), 2) investigate the 
prevalence of insomnia and the relationships between sleep and functioning (emotional and 
physical) (study I), 3) identify and evaluate existing research on intensive interdisciplinary 
treatment (IIPT) for pediatric chronic pain (study III), 4) investigate the effects of Acceptance 
and Commitment Therapy (ACT) on functioning in a clinical pilot study of individual and 
group treatment for adolescents with chronic pain (study IV) and 5) investigate the effects of 
parental support based on ACT on functioning in a clinical pilot study of individual and 
group treatment for parents of adolescents with chronic pain (study IV).  
Methods: Psychometric properties of the ISI and the PII were evaluated using cross-sectional 
data from pediatric participants with chronic debilitating pain. Evaluations included principal 
component analysis, correlational and regression analyses, and analysis of internal 
consistency. The importance of insomnia for the relationships between pain intensity, 
depression and functional disability were assessed by examining the indirect effects of 
insomnia in the relationship between pain and depression, and between pain and functional 
disability. To evaluate the current evidence for IIPT for pediatric chronic pain, a systematic 
review and meta-analysis was conducted. Finally, to investigate the effects of individual and 
group ACT treatment for adolescents with chronic pain and their parents, non-parametric 
analyses of differences between groups and over time were conducted, as well as analyses of 
clinically significant changes for adolescent and parent outcomes.  
 
  
Results: Results from the psychometric evaluations in study I and II supported the concurrent 
criteria validity and reliability for the ISI and the PII in this sample. The principal component 
analysis supported a 1-factor solution for PII. More than half of the sample reported clinically 
relevant scores of insomnia, and indirect effects of insomnia were found for the relationships 
between pain and depression, and between pain and functional disability. In study III, the 
systematic searches resulted in 10 studies matching criteria for inclusion (1 randomized 
controlled trial and 9 non randomized studies), and the meta-analysis yielded preliminary 
evidence for positive treatment effects of IIPT, but findings showed substantial heterogeneity. 
In study IV, adolescents reported significant improvements in functioning outcomes (i.e. pain 
interference, pain reactivity, depression, and psychological flexibility). Parents reported 
improvements in parental pain reactivity and psychological flexibility. There were no 
differences between group and individual treatment, and the pattern of results illustrated 
significant changes during the second half of treatment. Clinically significant changes were 
reported to a large extent in adolescent (21-63%) and parent (54-76%) variables.  
Conclusions and further directions: The PII and ISI are reliable and valid instruments that 
can be used to assess pain interference and insomnia in children and adolescents presenting 
with chronic pain. IIPT holds promise as a treatment format for addressing pain and pain-
related dysfunction, but due to a small number of studies and methodological weaknesses, 
more research in this field is needed. The treatment evaluation of ACT for adolescents with 
chronic pain supported the promising findings from previous studies, illustrating 
improvements in adolescent functioning after treatment. Also, results indicate the utility of 
the ACT based parent support. Particularly, larger clinical trials with rigorous methodology 
are needed to evaluate the relative utility of individual and group treatment formats, 
mechanisms of change and the effects of parental support programs.  
  
  
 
POPULÄRVETENSKAPLIG	SAMMANFATTNING	
Långvarig smärta är vanligt hos barn och ungdomar, och drabbar mellan 11-38%. En del av 
dem som drabbas upplever också omfattande smärtrelaterade svårigheter, till exempel 
depression, fysisk funktionsnedsättning, och problem i kamratrelationer. Det är även vanligt 
att föräldrar till barn med långvarig smärta mår dåligt.  
Behandlingar som är inriktade på beteendeförändring har visat sig fungera för att minska 
smärta och öka funktionsförmåga, men många frågor kvarstår, till exempel rörande det 
vetenskapliga stödet för effekter av intensiva teambaserade behandlingsprogram för 
inneliggande patienter, eller skillnader mellan individuella och gruppbaserade insatser i 
öppenvård. Det behövs också mer kunskap om hur vi på ett effektivt sätt kan behandla 
depression hos barnet, och hjälpa föräldrar att må bättre och hantera sina barns svårigheter på 
ett mer funktionellt sätt. Vidare behövs fler frågeformulär för att utvärdera olika 
smärtrelaterade svårigheter, som är specifikt utvecklade för barn och ungdomar med 
långvarig smärtproblematik.  
I detta doktorandprojekt utvärderas två olika frågeformulär. Det ena, Insomnia Severity Index 
(ISI) (studie I) syftar till att mäta sömnproblem såsom svårigheter att somna, nattliga 
uppvaknanden, och påverkan av sömnproblem dagtid. ISI är ett välanvänt formulär världen 
över men har inte tidigare utvärderats i svensk översättning för just barn och ungdomar med 
långvarig smärta. Det andra formuläret, Pain Interference Index (PII) (studie II) är ett 
nyskapat formulär som syftar till att mäta hur mycket smärtan påverkar ens beteenden i 
vardagen. Vidare har vi undersökt det vetenskapliga stödet för ett särskilt behandlingsformat, 
intensiv interdisciplinär smärtbehandling (IIPT) för barn och ungdomar med långvarig smärta 
(studie III). Dessutom utvärderas effekterna av Acceptance and Commitment Therapy (ACT) 
för ungdomar med långvarig smärta och deras föräldrar, genomförd i grupp eller individuellt 
(studie IV).  
Som underlag för analyserna användes frågeformulär från barn och ungdomar med långvarig 
smärta och deras föräldrar (studie I, II och IV), samt ett antal vetenskapliga artiklar som 
lokaliserats genom sökande i digitala databaser på ett systematiskt sätt och därefter 
sammanställts för analys (studie III).  
 
  
Resultaten visar att de båda frågeformulären PII och ISI som utvärderades i studie I och II på 
ett tillförlitligt sätt mäter det kliniska problem de är tänkta att mäta, och vi såg även att 
påtagliga sömnproblem rapporterades av mer än hälften av de barn och ungdomar som ingick 
i studien. Analyserna pekar också på att sömnproblem spelar en viktig roll i sambandet 
mellan smärtintensitet och depression, och mellan smärtintensitet och smärtrelaterade 
begränsningar (pain interference).  
När det gäller det vetenskapliga stödet för IIPT så kunde vi se preliminära positiva effekter 
från de 10 studier som ingick i vår sammanställning (studie III). Dock var resultaten ojämna, 
och det skulle behövas fler studier med andra typer av upplägg (till exempel där effekterna av 
IIPT-behandlingen jämförs med effekterna av en annan behandling, eller av att vara placerad 
på väntelista, och där deltagarna lottas till de olika grupperna) för att man ska kunna dra säkra 
slutsatser.  
I behandlingsutvärderingen av ACT (studie IV) så rapporterade både ungdomar och föräldrar 
förbättringar inom ett flertal områden efter genomgången behandling, till exempel minskad 
påverkan av smärta på beteenden, minskad depression samt minskad känslomässig reaktivitet 
(oro, ilska, med mera) i relation till barnets smärta.. Det framkom inga skillnader mellan de 
som hade lottats till individuell behandling jämfört med dem som hade lottats till 
gruppbehandling. Dock behövs studier med fler deltagare, för att säkerställa dessa 
preliminära resultat. 
Denna doktorsavhandling bidrar med ökad kunskap om effekter av olika 
behandlingsinterventioner och format, och kan ligga till grund för fortsatta studier inom 
området långvarig smärta hos barn och ungdomar, samt vidareutveckling av effektiva 
behandlingsinsatser för smärtrelaterad funktionsnedsättning. Vidare innebär resultaten från 
utvärderingarna av PII och ISI att de kan rekommenderas för användning i kliniska 
sammanhang för att mäta förekomst av sömnproblem och smärtpåverkan på beteenden i 
samband med bedömning och behandling. De kan även rekommenderas för användning i 
fortsatt forskning om sömnproblem och smärtans påverkan på beteenden, och de samband 
som finns mellan dessa problem och andra relaterade svårigheter, hos barn och ungdomar 
med långvarig smärta. Behovet av mer kunskap är fortsatt stort, och andra metoder för 
datainsamling och analys, såsom kvalitativa intervjustudier, eller många upprepade mätningar 
över tid med hjälp av digitala verktyg, kan ge viktig information i framtida studier. Likaså 
behövs utvecklingsinsatser för att säkerställa att de behandlingsinterventioner som visat sig 
vara effektiva för långvarig smärtproblematik når ut till de barn och föräldrar som är i behov 
av hjälp.   
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1 INTRODUCTION  
Pediatric chronic pain is common and often related to dysfunction. The complexity of the 
problem implies the need for further investigation of how pain-related dysfunction can be 
addressed in treatment. There is also a need to develop and implement valid and reliable 
assessments for outcomes of treatments aimed at increasing functioning in pediatric chronic 
pain.  
1.1 Pediatric chronic pain – definitions and diagnoses 
The International Association for the Study of Pain (IASP) defines pain as “An unpleasant 
sensory and emotional experience associated with actual or potential tissue damage, or 
described in terms of such damage”. In this definition IASP stresses, regardless of type, that 
the pain experience is psychological (1), lacking objective measurement. Pain is always 
complex (2) and subjective (3). Pain and pain syndromes are defined and classified according 
to a set of principles (1). In children and adolescents, i.e. pediatric populations, 3 months is 
generally considered the cut-off for when pain is referred to as chronic, for both clinical and 
research purposes, but 2 months is also a common cut-off, used for functional gastrointestinal 
disorders in particular (1, 4, 5). Though chronic pain syndromes can result from tissue 
damage (e.g. inflammation) or nerve damage (e.g. from amputation), pediatric chronic pain 
often lacks a primary or clear etiological cause (6). Such pain has been referred to as 
idiopathic pain, functional pain and, more recently, primary pain disorder (6-9). In the 
definition of this last term, it is highlighted that the pain is often related to other problems, 
such as sleep difficulties and impaired emotional functioning which in turn hampers the 
return to normal functioning (7).  
1.2 Prevalence and risk factors  
Chronic pain is highly prevalent in pediatric populations, affecting between 11% to 38% as 
shown in a systematic review from 2011 (10). In a Norwegian community sample of 
adolescents (n=7373), up to 44% reported pain at least once a week over the past 3 months 
(11). Prevalence rates vary depending on age and gender, pain location, and how pain has 
been defined and reported (10, 12). More girls than boys report chronic pain, and the 
prevalence of pain, and multiple pains, increases with age (10-13). Pediatric chronic pain has 
been shown to persist into adulthood (14-16), which indicates the need for early 
interventions. In order to understand who is at risk for developing chronic and debilitating 
pain, a large number of factors have been investigated and shown to be of importance. As 
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described in a recent review of by McKillop and Banez (17), these include intra-individual 
differences in for example temperament, perceived stress, adverse life events, mental health 
and coping, demographic factors such as age and sex, and inter-individual aspects in social 
relations, parenting, and presence of psychopathology and chronic pain in the parent (17). 
However, more knowledge is needed regarding how developmental aspects and co-existing 
intra- and interpersonal risk- and protective factors, are related over time. The need for more 
and better-conducted studies is also put forth in a recent review of risk and prognostic factors 
for pediatric musculoskeletal pain (18). Using the Grading of Recommendations Assessment, 
Development and Evaluation framework for assessing quality of evidence (GRADE), the 
authors found high quality evidence only for lower socio-economic status. Because many 
children and adolescents with chronic pain also report dysfunction, using functional ability as 
an outcome measure is an important addition in studies of risk and prognostic factors of 
future health (17). Further, more research is needed regarding gender differences in pediatric 
chronic pain, to improve our understanding of pain related disabilities, and identify predictors 
for future functioning (19).  
1.3 Pain and dysfunction 
Chronic pain in youth is commonly associated with physical, emotional and social 
dysfunction. Although some report minor influence of pain in everyday life, a subset of 
young individuals suffering from chronic pain report substantial impairment (11). In a study 
by Huguet and Miró (13), about 5% of the 37% who had chronic pain reported moderate or 
severe pain-related disability. Associations between chronic pain and disability has been 
shown in most life domains for children, from broad categories of physical, emotional and 
social functioning to more specific areas such as sleep and school attendance (20-22). 
Concurrent self-report, parent report, and objective assessment of physical activity 
(actigraphy) have altogether shown adolescents with chronic pain to be less physically active 
than healthy controls (23). In the Norwegian study (n=7373), multisite pain and pain that 
occurred more frequently were both associated with more disability, as compared to pain in 
one location and pain that occurs more seldom (11) and in this study, depending on pain type 
and number of locations, between 30-64% of adolescents with chronic pain reported that this 
pain caused difficulties sitting during school lessons. When compared to adolescents without 
chronic pain, and adolescents with pain related to Juvenile Idiopathic Arthritis, youths who 
had a primary pain condition were found to have worse school functioning, missed school 
days to a much larger extent, and visited the school nurse more often (24).  
  3 
1.3.1 Mental health co-morbidity 
A growing body of research supports the presence of co-morbid mental health conditions in 
pediatric chronic pain, and the reciprocal relationship between chronic pain and mental health 
symptomatology (25). In a large retrospective investigation of children admitted to hospital 
because of chronic pain (n=3752) (26), 44% were diagnosed with co-morbid psychiatric 
disorders. Hoftun and colleagues (27) also found strong associations between pain, anxiety 
and depression in their large community sample (n=7373), and where the associations 
influenced the relationship between pain and lifestyle factors such as sedentary behavior. In 
this study, 81% of girls scoring above the cut-off for symptoms of anxiety and depression 
also had chronic non-specific pain. In a longitudinal study of adolescents with chronic pain, 
and adolescents with depression, reciprocal associations were seen between pain and 
depression, with the strongest influence being that of changes in pain on subsequent 
depression (28). Furthermore, the presence of depression and anxiety is linked to functional 
disability in clinical samples of pediatric chronic pain patients (29, 30). Pain-related anxiety 
has been put forth as owning specific relevance for impairment in functioning. For example, 
Caes, Fisher, Clinch, Tobias, and Eccleston (31) found in a large sample of adolescents 
reporting recurrent pain (n=856) that pain-related anxiety was associated with pain-related 
interference in daily activities, and for girls specifically, pain related-anxiety was related to 
social impairment. Khan and colleagues (32) examined anxiety and school functioning 
(attendance, concentration, and keeping up with schoolwork) using child, parent and clinician 
reports, and by use of structural equation modeling. Anxiety was found to directly influence 
all three domains of school functioning, when controlling for pain, and the authors stress the 
importance to focus on anxiety rather than pain when targeting school impairment in youths 
with chronic pain.  
In addition to the emotional distress related to having chronic pain conditions in adolescence, 
having a chronic pain condition in youth is also associated with increased lifetime risk for 
mental health problems (33-35), and mental health problems are related to more dysfunction 
when present together with chronic pain. For example, in adults with chronic pain, recent data 
from a tertiary sample show a high prevalence of co-morbid depression, which was related to 
higher health care costs, and to several other pain-related aspects of dysfunction (e.g. work 
absence and interference with functioning) (36). 
Thus, the common presence of mental health co-morbidity in pediatric chronic pain as well as 
the increased risk of anxiety and depression in adulthood, and related health care costs, 
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illustrates the complexity of the condition and the need to address emotional dysfunction as 
part of treatment.  
1.3.2 Sleep problems 
Sleep problems in adolescence include for example delayed sleep onset time, daytime 
sleepiness and insomnia, and sleep problems are commonly related to distress or impaired 
functioning in general adolescent populations (37). Research based on different 
methodological approaches support that sleep problems are related to negative effects on 
cognition and behavior, and likely to cause both inattention and sleepiness, which altogether 
can affect the development of a young individual over time (38). Findings from a systematic 
review of 141 studies showed that shorter sleep duration is related to poorer mental and 
physical health in youths (39). Another example of the negative effects of sleep problems is 
the result from a meta-analysis of 21 longitudinal studies of insomnia and depression (three 
of the studies were conducted with children and adolescents), where insomnia consistently 
predicted depression (40). In an early study of Archbold and colleagues (41), insomnia 
appeared as the most common sleep disorder among patients at two pediatric clinics. The co-
morbidity of insomnia or short sleep duration and obesity and metabolic syndrome, as well as 
other medical conditions and their relationship to various sleep disturbances in pediatric 
populations, has also been acknowledged (42). Despite the potentially detrimental effects of 
sleep problems on the development of children and adolescents, there is often a lack of proper 
screening and management of insomnia and other sleep problems in pediatric clinical samples 
(43, 44).  
Concerning pain and sleep, a bi-directional association is assumed, as studies have shown 
both that pain affects sleep, and that sleep affects pain (45-48). Findings from a systematic 
review of 56 studies conducted with pediatric patients with chronic pain conditions (49) 
support the link between sleep problems and chronic pain, as shown with both objective and 
subjective sleep measures, and also indicates the importance of sleep problems for 
functioning in the context of chronic pain. Focusing on results from single studies, the high 
prevalence of significant sleep problems can be exemplified by the findings from Long and 
colleagues (50) where 53% of pediatric chronic pain patients scored above cut-off for 
clinically significant sleep disturbances, and Shurman and colleagues (51), where nearly half 
the sample of children with chronic abdominal pain categorized as functional gastrointestinal 
disorders reported clinically significant sleep problems. Palermo and colleagues (52) 
compared healthy youths from the community with youths who had chronic pain recruited 
from a pain clinic, and found that the risk for insomnia was significantly higher in the group 
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with chronic pain as compared to healthy youths. In the chronic pain group, 54% reported 
either difficulties falling asleep or staying asleep, versus 20% in the control group.  
In addition to the bi-directional associations between pain and sleep, it has been suggested on 
basis of studies including pediatric populations (53) that sleep may influence chronic pain 
more than pain influences sleep, and that targeting sleep thus may be a way forward in both 
prevention and treatment of chronic pain. For young adults from the general population, 
Bonvanie and colleagues (54) found that sleep problems were associated with chronic pain 
and pain severity, and predicted chronic pain and exacerbation of pain severity over time. 
How the relationship between sleep and pain is affected by mood or emotions should be 
subject for further exploration (53). Though relationships between depression, functional 
disability and sleep in pediatric chronic pain have been reported in several articles (see e.g. 
(21, 50, 55)), specifically how these factors interrelate need more investigation. In the study 
by Palermo and colleagues (52), cognitive arousal such as worry and anxiety was related to 
increased risk for insomnia, and in a prospective study with adolescents with chronic pain, 
pain, depressive symptoms and sleep hygiene were risk factors for later symptoms of 
insomnia (56). In a recent cross-sectional study of 213 pediatric participants with chronic 
pain (57), 74% reported sleep problems, which were associated with increased pain and 
functional disability. In this study, negative affect was found to mediate the relationship 
between poor sleep and increased pain, and the relationship between sleep and functional 
disability was mediated by both positive and negative affect. 
Taken together, the prevalence and importance of sleep problems in pediatric populations and 
in the context of pain highlight a need for studies further exploring the complex relationships 
between pain, sleep and other factors, e.g. evaluating the importance of insomnia in 
mediating the relationship between symptoms and functioning.  
1.3.3 Pain interference  
As described above, chronic pain in youth is commonly associated with dysfunction in 
physical, as well as emotional and social aspects of life. The impact of pain, or pain 
interference, in all these aspects is important both as a clinical outcome and in 
communicating with and understanding the patient (58, 59). Pain interference addresses an 
overall reactive dimension of having pain, such as the impact of pain on an individual’s sense 
of engagement, rather than, say, the perceived ability to carry out physical activities (60). To 
meet the need for a measure of pain interference that is appropriate for different ages and 
developmental stages, and at the same time useful for both clinicians and researchers in the 
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pediatric chronic pain context, two initiatives have been taken. First, a co-operative network 
of researchers created a pain interference scale for the Patient Reported Outcomes 
Measurement Information System (PROMIS-PI) (61, 62). In a parallel process, our research 
group created the Pain Interference Index (PII). The PII was created on basis items included 
in the West Haven-Yale Multidimensional Pain Inventory (MPI) (63) and the Brief Pain 
Inventory (BPI) (64) but items were re-formulated with the attempt to create an age-
appropriate measure. (The methodology and results from the development of PII is presented 
in 2.2 and onwards.) Pain interference as defined in the process of creating the PII concerns 
the influence of pain on behaviors, that is, to what extent pain impacts everyday functioning. 
Both PII and PROMIS-PI cover pain interference in relation to schoolwork, leisure activities, 
friends, mood, physical activities and sleep, and as such they might offer a way to assess 
several domains of pain-related dysfunction without having to administer several different 
questionnaires. In an adult sample, higher pain interference was correlated to lower physical 
functioning, but these constructs were not as strongly correlated when measured over time 
(60). Thus, it seems important to clarify the construct of pain interference and the use of the 
term in research (65) i.e. that pain interference concerns the overall impact of pain on 
everyday functioning - it is not just a proxy measure of physical functioning/disability. 
Notably, in pediatric chronic pain, the PROMIS-PI scale has recently been evaluated using 
longitudinal data (66). Results from this study support both the validity and the 
responsiveness to change for the interference scale, in a sample of pediatric patients with 
chronic pain attending a multi-disciplinary chronic pain clinic.  
Further research in pediatric samples is needed to evaluate pain interference in relation to 
specific physical and emotional disability, and the utility of pain interference as a key 
outcome after behavioral treatment interventions.  
1.3.4 Parent and family aspects 
Pain in children and adolescents has a negative impact on the whole family, and is associated 
with e.g. parental depression, anxiety, stress and economic burden (67-71). In a qualitative 
study from 2007 (72), parent’s reported a difficult struggle dealing with their adolescent’s 
pain and experienced a major impact on both parenting strategies and life as a whole, e.g. 
managing siblings and maintaining a normal personal life. These difficulties in parenting a 
child with chronic pain were expressed in a second qualitative study, focusing specifically on 
fathers, where feelings of helplessness was one of the major themes in interviews (73). In a 
systematic review from 2010 (69) covering 16 cross-sectional studies, a general pattern 
emerged where poorer family functioning was reported in families where the child suffered 
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from chronic pain as compared to healthy controls, and that pain disability posed more of a 
problem than pain intensity, in relation to family functioning. Thus, it seems child 
dysfunction in relation to pain rather than the actual level of pain, is what matters for family 
functioning. Furthermore, Chow and colleagues (74) reported that parent distress (fear of pain 
and catastrophizing) and behavior (avoidance of activities and protective behavior) was not 
just associated with child functioning at baseline, but also that parent behaviors significantly 
predicted child depression and school functioning at four months post the intervention 
(described as a combination of medical, physical and psychological interventions). On basis 
of these findings, parent factors are stressed as important treatment targets in future 
intervention studies for children with pediatric chronic pain (74).  
In addition to emotional, physical and social family functioning, impact on the socio-
economical status is also commonly seen in relation to pediatric chronic pain. Researchers 
have highlighted significant health care and societal costs for pediatric chronic pain patients 
and their families (75, 76). In a study by Groenewald and colleagues (75), both direct medical 
costs and productivity losses were examined in a sample of 149 adolescents with chronic 
pain, and the mean and median cost for a 12 months period was estimated to $11,787 and 
$6,770, respectively. This illustrates the importance of effectively addressing pediatric 
chronic pain, in order both to improve the socio-economic status for suffering families and to 
lessen the strain on the health care system.  
Parents of children with chronic pain commonly report own chronic pain (77), i.e. there is an 
increased risk for pain and related problems in children of parents with chronic pain. In 
addition, adult chronic pain, akin to pediatric chronic pain, is also related to poor emotional, 
physical and social functioning, which may have detrimental effects on the family 
environment (78). In systematic reviews, a range of adverse outcomes has been identified in 
children where parental chronic pain is present (79, 80). Findings from a large population 
based sample of adolescents in Norway (n=3227) showed that presence of maternal and 
paternal chronic pain more than doubled the risk for depression and anxiety in both girls and 
boys, and maternal chronic pain showed to be a significant risk factor for conduct problems 
in girls (81). The prevalence of maternal and paternal chronic pain in this study was high 
(27% and 24%, respectively, which can be compared to the prevalence of chronic pain in 
adults in general, e.g. about 19% of the population in USA. (82)).  
Thus, given the importance of parental factors in pediatric chronic pain, there is a critical 
need to develop evidence based parental support for parents of children with chronic pain.  
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1.4 Psychological treatment approaches  
For most chronic pain conditions in both adult and pediatric populations, the use of traditional 
pharmacological and surgical interventions does not lead to desired outcomes in terms of 
sufficient levels of pain reduction and/or improvements in functioning (6, 83). Nevertheless, 
findings from a retrospective study of highly impaired pediatric pain patients (n=2249), 
illustrated that indication for pharmacological treatment was lacking for 43% of the patients 
that were taking analgesic medication (33% of the total sample) (84). This further illustrates 
the need for other treatment approaches for these patients, such as behavior oriented 
rehabilitation programs, which are widely considered a more effective alternative to medical 
interventions for chronic pain (83). Below, two such behavioral approaches are described, as 
well as one distinct format of delivery of behavioral interventions.  
1.4.1 Cognitive behavior therapy (CBT)  
Cognitive Behavior Therapy (CBT) as we know it today has its origins in learning theory and 
experimental research, including the early work conducted by Pavlov more than a hundred 
years ago on classical (also known as associative or respondent) learning, and subsequently 
by Skinner on operant learning, where the consequences following a behavior affects the 
likelihood for, i.e. reinforces, particular future behaviors (85). Behavior therapy showed to be 
successful in a number of areas previously considered unmanageable, including but not 
limited to many anxiety disorders. CBT then evolved during the 1960’s and 1970’s to include 
interventions based on cognitive processes. In more recent years, the continuous development 
of CBT has resulted in advances in learning theory as illustrated by e.g. Relational Frame 
Theory, and the incorporation of mindfulness and acceptance techniques, as seen in 
Acceptance and Commitment Therapy (described in more detail in 1.4.2) (85).  
CBT includes many psychological interventions in child and adolescent populations, and 
there is robust evidence for CBT to manage pain and procedural distress (86). CBT is focused 
on the experiences and behaviors of an individual in given situations, and CBT-programs are 
normally aimed at improving symptoms and functioning. Pain-related feelings, thoughts and 
overt behaviors, such as avoidance of activities or situations assumed to increase pain, are 
assessed as part of treatment, and interventions are tailored and carried out in order to help 
the patient adapt and adjust according to specified goals (87-89).  
A Cochrane systematic review and meta-analysis from 2014 evaluated the evidence for 
psychological interventions (primarily CBT, and only delivered face-to-face), for chronic and 
recurrent pediatric pain (88). In this review, findings from 37 randomized controlled trials 
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(RCTs) included beneficial effects from psychological treatments for children suffering from 
headache in regard to pain intensity, disability and anxiety but not depression post treatment, 
with support for maintenance of effects over time for the change in pain and disability but not 
anxiety. For children with non-headache conditions, beneficial effects were found post 
treatment for pain and disability, but no evidence was found for maintenance of effects at 
follow-up. Further, effects for depression or anxiety were not found in this group at post or at 
follow-up (88).  
Notably, of the 37 RCTs included in the Cochrane review, only 6 studies could be included in 
analyses of effects on depression. A similar pattern was found in an unpublished systematic 
review of depression outcomes in psychological treatment evaluations for pediatric chronic 
pain, including both RCTs and non-randomized treatment evaluations (90). Out of 91 eligible 
studies, only 24 of these examined depression as an outcome (i.e. not just descriptively), and 
17 of these studies described significant effects on depression, either pre to post, or pre to 
follow-up.  
Given what we know about the complexity of pediatric chronic pain and mental health co-
morbidity, the fact that few studies exist where depression and anxiety have been included as 
outcomes and even fewer that report lasting improvements in these domains, highlight the 
need for future intervention studies to address more than pain, i.e. emotional adjustment and 
sleep difficulties, and to evaluate these outcomes with valid and reliable assessments.  
1.4.2 Acceptance and commitment therapy (ACT) 
Acceptance and Commitment Therapy (ACT) constitutes a development within CBT, and is 
theoretically founded in contextual behavioral science (CBS) (91) and based on Relational 
Frame Theory (RFT), a novel theory of human language and cognition with a growing 
evidence base (92, 93). RFT originated in the question of how verbal rules guide human 
behavior (94). In ACT, a core feature is the focus on changing the context around our 
thoughts, emotions and experiences, i.e. our relationship to them, rather than the content or 
intensity of them, thereby changing the impact that they have on our behavior. ACT serves to 
increase psychological flexibility, defined as “the ability to contact the present moment more 
fully as a conscious human being, and to change or persist in behavior when doing so serves 
valued ends” (p. 7 in (95)). In ACT, several processes are suggested as important for 
increased psychological flexibility: Acceptance of psychological experiences (thoughts, 
feelings, sensations), cognitive defusion, flexible present-focus attention, and self-as-
context/observer, i.e. awareness and perspective taking on psychological experiences rather 
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than being caught up in them or trying to disconnect or distract from them and from the 
present, and awareness of being distinct from on-going thought and emotional processes, and 
values-based action and committed action, i.e. active focus on what is important in life and 
how to achieve that, instead of focusing on reducing symptoms and distress (96, 97). 
Exposure to previously avoided situations is considered central to achieving behavior change, 
and acceptance of persisting symptoms is thus promoted as an alternative to avoidance. 
Though still a novel approach for the pediatric population, ACT akin to CBT has already 
been used to treat a variety of conditions, most commonly pain, as seen in a systematic 
review from 2015 (98). Studies that have been conducted provide support for the 
effectiveness of ACT for pediatric populations with pain and other physical concerns, but this 
support is compromised by the preliminary nature of the evidence as existing studies vary 
greatly in methodological quality, with small sample sizes being a prominent limitation (98, 
99). When Pielech, Vowles and Wicksell summarized the theory and application of ACT for 
pediatric chronic pain, they also suggested the need for studies with larger samples and 
controlled study designs, as well as the need for continued focus on mechanisms of change, 
and the inclusion and assessment of parents in treatment (100).  
The primary aim in ACT for chronic pain conditions is to increase functioning. Instead of 
focusing on symptom reduction, the ability to engage in valued activities despite the presence 
of potentially disturbing and distressing experiences and symptoms such as pain, is the focus 
of the treatment (i.e. psychological flexibility) (95, 101). There is a growing evidence base 
suggesting the effectiveness of ACT for adults with chronic pain, in improving physical and 
emotional functioning in particular (see e.g. (102)), and ACT is now considered a treatment 
with strong research support for chronic or persistent pain by the Society of Clinical 
Psychology, American Psychological Association (103).  
Our research group in Stockholm has evaluated an ACT-based outpatient intervention in a 
series of studies including pediatric participants with chronic pain. In the first study, a case 
study from 2005 (104), increased values-oriented activities, increased functioning, and 
decreases in pain and disability was reported by the participant during and after treatment. 
The second study was a pilot study of the individually delivered ACT-intervention (n=14) 
(105). Here, a similar pattern of increased functioning, including increased school attendance 
and clinically important changes in pain and pain interference was seen for a majority of 
participants. In the third study, a RCT (106), the ACT-intervention was compared to a multi-
disciplinary approach (MDT) including amitriptyline (total n=32). Treatment in the control 
group continued after post-assessments, which complicated comparisons between the groups. 
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Both groups improved significantly over time on most outcomes, with the ACT-group having 
statistically better results as compared to MDT in 3 of 11 outcomes when including follow-up 
measures (pain impairment beliefs, pain intensity, pain discomfort), and 6 out of 11 outcomes 
when compared post treatment (pain impairment beliefs, pain interference, the mental health 
scale for Short Form Health Survey, fear of movement, pain related discomfort and pain 
intensity). In the Cochrane-review (88), this RCT was one of few studies reporting depression 
as an outcome, with a medium effect size for the ACT-condition and a small effect size for 
the MDT over time, including follow-up assessments. When compared at post-treatment, the 
difference in improvements in depression between MDT and ACT was near statistical 
significance in favor of ACT (p=.055, medium effect size).  
The utility of specifically targeting ACT-based processes of change, i.e. psychological 
flexibility, to improve functioning was analyzed using data from the RCT (107). Here, 
analyses of mediators of change were conducted with depression and pain interference as 
outcomes. Six variables, which represented treatment targets of importance for ACT and 
CBT respectively, were tested as mediators. Results suggested that changes in pain 
impairment beliefs and pain reactivity, which are consistent with ACT-theory, mediated 
outcomes, but self-efficacy, catastrophizing, fear of movement, and pain intensity, targets 
more common in traditional CBT-interventions, did not. In the ACT-condition, pain 
impairment beliefs and pain reactivity also predicted depression and pain interference at 
follow-up, with control for previous effects (107).  
Another ACT-based program for adolescents, in the UK, with residential patients, has also 
been shown to improve functioning in severely disabled adolescents with chronic pain (n=98) 
(108). Following the 3-week program, adolescents improved in self-reported functioning 
across a number of variables, and in objectively measured physical performance. Significant 
effects were seen both post-treatment and at 3-months follow-up. Notably, no significant 
changes were reported for pain intensity. Acceptance during treatment was correlated with 
sustained changes in outcome measures at follow-up, which adds further promise to ACT-
processes as treatment targets that might serve to improve functioning outcomes (108). 
In addition to these programs, a few more studies on ACT-interventions for pediatric chronic 
pain exist, conducted in for example Iran (109) and USA (110). However, ACT is still a 
novel approach when used with pediatric patients who suffer from chronic pain. The current 
evidence is promising, as improvements in functioning have been consistently reported, and 
further developments are thus warranted. 
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1.5 Formats of treatment delivery 
Psychological treatment approaches for pediatric chronic pain can be delivered in various 
formats, such as individual face-to face therapy, group-delivered interventions for patients 
with similar pain characteristics, and multi-disciplinary approaches of different intensity, 
from outpatient interventions to residential (87, 88, 111). Further, a separate Cochrane review 
has evaluated the current evidence for remotely delivered psychological therapies for 
pediatric chronic pain (112). Regarding ACT specifically, existing studies have examined 
both individual interdisciplinary outpatient treatment (for example (106) and group-delivered 
interdisciplinary residential treatment (108), although no head-to head comparisons between 
treatment formats (i.e. with the same treatment content) have yet been made. Thus, this 
should be investigated in future studies. Furthermore, no study had prior to the present 
doctoral project systematically synthesized the outcomes from intensive interdisciplinary 
treatments for pediatric chronic pain.  
1.5.1 Intensive interdisciplinary pain treatment (IIPT) 
For patients with severely debilitating pain, it is commonly proposed that an intensive and 
interdisciplinary setting is required to facilitate improvement. As described by Odell and 
Logan (111), intensive interdisciplinary pain treatment (IIPT) programs are characterized on 
the one hand, by the multi-modal treatment team, which can include physicians, 
psychologists and physiotherapists, as well as for example nurses, occupational therapists or 
counselors, all specialized in the assessment and management of pain, and on the other hand, 
by the intensity of treatment delivery, which has either an inpatient or a day hospital setup (as 
opposed to outpatient treatment). In IIPTs, there is a strong focus on physical rehabilitation, 
and on the psychological management of pain, by means of behavior/CBT/ACT-interventions 
(111). Parents are also commonly included in treatment. Positive outcomes for children have 
been reported from a number of treatment centers, including greater improvements for IIPT 
in comparison both to outpatient treatment (113, 114), and to waiting-list control (115). There 
is also support for statistically and clinically significant long-term effects after IIPT (116), as 
well as cost-effectiveness (117). However, though specialized rehabilitation programs around 
the world for children and adolescents with debilitating chronic pain are similar in many 
aspects (e.g. admission criteria, structure, components, and interdisciplinary approach (as 
described recently in (118)), there is variation in treatment setting, dose and treatment 
components, along with routines for evaluation and follow-up. Thus, more research is needed 
regarding the current empirical support for IIPTs, to facilitate further development and 
implementation.  
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1.6 Parental interventions  
As discussed in 1.3.4, it is common for parents of children with chronic pain to experience 
distress that affects their ability to effectively support their child in doing what is required to 
retain or improve functioning (119-121). Parents are therefore often included in the treatment 
of children with chronic pain.  
1.6.1 CBT-interventions for parents 
In CBT-interventions for parents, focus has commonly been on targeting parent behaviors 
that might have an effect on child functioning, for example by teaching parents operant 
techniques for behavior modification (120). An early non-controlled evaluation of an 
interdisciplinary CBT-program for adolescents with chronic pain and their parents included 
parent stress and parent anxiety and depression as outcomes (n=57 adolescent-parent dyads) 
(67). In this study, which included interventions based on operant learning and CBT-
principles, improvements were seen in parent anxiety, depression and parent stress, and 
continued to improve at 3-months follow-up. Focusing specifically on the CBT-intervention 
problem solving skills for parents of pediatric chronic pain sufferers has also shown 
promising results, for example near significant reductions in parent depression as compared 
with the treatment as usual-control group, with a medium effect size (p= .06, d= -0.68) (122).  
However, when synthesized, the existing evidence for benefits for parents after receiving 
parental interventions in the context of pediatric chronic pain is still limited, as seen in a 
Cochrane systematic review from 2015 (121). Here, the effectiveness of psychological 
therapies for parents of children with chronic illnesses was examined. A total of 47 RCTs 
were included, and 14 of these concerned children with painful conditions. The interventions, 
primarily CBT-based, included a varying proportion of parent sessions, from parent sessions 
only, to majority of treatment sessions aimed at the child. For painful conditions, analyses 
showed that parent interventions were useful in reducing child pain related symptoms post-
treatment (based on 9 studies), with a small effect, but this was not maintained at follow-up 
(based on 6 studies). Based on 2 studies, no effect was found for improvements in parent 
adaptive behaviors post-treatment. Analyses of child outcomes post treatment (7 studies) and 
at follow up (3 studies), showed no beneficial effects for reducing child disability, or for child 
mental health improvements post treatment (4 studies) or at follow up (2 studies). No study 
evaluated parent mental health outcomes (121). Based on these findings, the authors 
suggested improvements in trial design, as well as regarding measurement and evaluation of 
outcomes. Furthermore, the authors specifically suggested future research on the relation 
between changes in parent outcomes and child outcomes, and that detailed descriptions of 
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how interventions to both child and parent were delivered should be provided, in order to 
enable an evaluation of the separate treatment components (121). Thus, the value of adding 
parental interventions for improving children’s functional outcomes is unclear, and more 
knowledge is needed regarding the relationships between child and parent factors in the 
pediatric chronic pain context. The parental processes central to the promotion of specific 
child outcomes, and the most effective implementation of parental interventions to this end, 
have yet to be investigated. A notable recent example of improved study design and reporting 
of parent outcomes is a multi-center RCT by Palermo and colleagues (123), comparing 
internet-delivered CBT (n=138) with internet-delivered education (n=135), where internet-
delivered CBT for adolescent with chronic pain was found to improve not only adolescent 
functioning but also decreased parent miscarried helping, parent anxiety, depression and self-
blame, and improved parent behavioral responses to pain. Parent modules included education 
about chronic pain and recognizing stress and negative emotions, education about and 
training in use of operant strategies and modeling, sleep and lifestyle, communication 
strategies, and relapse prevention (123). In a secondary longitudinal evaluation of this study 
(124), associations between child and parent functioning over the course of one year was 
examined. Parent distress (including depression, anxiety and catastrophizing regarding child 
pain) was found to predict child disability over time, indicating that parents who are highly 
distressed are also less effective in helping their child adapt to and implement behavioral pain 
management strategies. The authors stress the need for more research concerning 
interventions that ameliorate parent emotional functioning, and also improves pain outcomes 
for the child (124).  
1.6.2 ACT-interventions for parents  
In cross-sectional studies, parental ACT-processes have been put forth as potentially 
important treatment targets to improve child outcomes (125, 126). It is hypothesized that 
parents of children with chronic pain struggle with their own distress of seeing their child in 
pain and with worry about their pain condition, which prevents them from coaching their 
child flexibly and effectively towards long-term goals and values (125). Thus, parents also 
need to practice e.g. acceptance and perspective taking on thoughts and emotions, to increase 
their own psychological flexibility. ACT-specific pediatric chronic pain treatment programs 
like the one in the UK (108) and ours in Stockholm (see e.g. (106)) involve parents in 
conjunction with child treatment to a varying degree. ACT-processes are targeted with 
children and parents in a similar fashion in both these programs.  
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In a pilot study with pediatric patients with neurofibromatosis type 1 and chronic pain, the 
parents were also taught ACT-strategies, but though promising results were reported by the 
youth, for example reduced pain interference, findings for parent variables did not reach 
statistical significance (127). In a recent pilot trial investigating a group-based ACT-
intervention for parents of adolescents with chronic pain (n=6 parent-adolescent dyads at 
completion) (128), the intervention was found to be feasible and parents reported increased 
psychological flexibility at post and follow-up, and decreased parent protective responses and 
adolescent pain interference was seen at follow-up.  
Preliminary results from a manuscript in preparation (129), in which child and parent 
outcomes from the UK residential program have been evaluated (n=165 adolescents and 
parent dyads), show improvements in both adolescent functioning and parent outcomes. 
Improvements were reported in parent depression, parent acceptance, and parent 
psychological flexibility. Further, adolescents improved in functioning outcomes as well as 
pain acceptance. The changes in parent psychological flexibility were significantly related to 
changes in adolescent pain acceptance, while controlling for changes in functioning 
outcomes.  
Thus, the specific utility of training parents to deal with their own distress related to their 
child’s pain in an ACT-consistent manner may hold promise, and more research is needed to 
evaluate if ACT-treatment results in improved outcomes for parents.  
1.7 Assessment of pain-related dysfunction  
Patient reported outcomes (PROs) and related measures (PROMs) are important in the 
clinical as well as the research setting (130). The patient possesses exclusive knowledge that 
can shed light on outcomes that are crucial in many clinical domains (131). Pain disorders are 
illustrative of the importance of patient reported outcomes, with the full pain experience only 
truly known to the sufferer, as pain and pain-related dysfunction can only to some extent be 
estimated and reported by proxy.  
Almost ten years ago, a network of researchers, the Pediatric Initiative on Methods, 
Measurement and Pain Assessment in Clinical Trials, (PedIMMPACT) (132) recommended 
that several areas should be taken into account in interventions for pediatric chronic or 
recurrent pain, there among physical, emotional and role functioning domains. The authors 
stressed the need for further evaluation of available instruments as well as the development of 
new instruments to fill the gaps identified, for example regarding co-morbid sleep difficulties. 
Notably, the PedIMMPACT refrained from recommending a particular assessment for sleep, 
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as there were no validated standard instruments for assessing insomnia/sleep problems in 
pediatric chronic pain patients. Similarly, Lewandowski and colleagues (133) stated on basis 
of a systematic review of sleep measures for the pediatric population that developing 
assessments of insomnia for the pediatric population should hold priority. Further, sleep 
outcomes were not presented in the Cochrane-review from 2014 (88), as only one study 
assessed sleep (134), and in a recent review of outcomes of specialized rehabilitation 
programs for children and adolescents with severe disabling chronic pain (118), only three 
studies reported sleep outcomes.  
Eccleston and colleagues (135) also noted a relative absence of valid and reliable assessments 
for many domains in pediatric chronic pain after conducting a review of previously used 
instruments in this population. Similarly, for parents of children with chronic pain (136), a 
systematic review of parental functioning measures showed both diversity and lack of 
consistency, as well as a need for more reporting of clinically relevant psychometric data for 
the available instruments.  
The transit towards functioning as the primary outcome in treatment for pediatric chronic 
pain is reliant on the development of valid and reliable instruments (137), both in clinical and 
research contexts. Thus, the development and psychometric evaluation of assessments 
particularly created for children and adolescents with chronic pain should be a priority for 
future investigations. Furthermore, consensus around functioning outcome domains and their 
assessments facilitate evaluations of existing empirical support, i.e. systematic reviews and 
meta-analyses.  
1.7.1 Development and psychometric evaluation of assessments 
In classical test theory (CTT), the approach to test development and evaluation is based on 
total scores, i.e. summaries of the scores for a set of items, where every observation 
represents the true score for an individual (i.e. the hypothetical score that would be the mean 
of observed scores from an unlimited number of test occasions) and measurement error (the 
random error part of the score we observe). Information about tests from the CTT-approach 
concerns psychometric properties of total tests and is specific to the sample in question (138-
140).  
1.7.2 Evaluating the reliability of assessments 
 In the Standards for Educational and Psychological Testing (141) p. 25, reliability is defined 
as “the consistency of [such ]measures when repeated on a population of individuals or 
groups. Reliability thus represents the dependability of results, and determining the reliability 
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of a scale is a part of the process whereby evidence for validity is gathered (142). The main 
goals in reliability analyses are to identify sources of random measurement error and their 
sizes, and the stability over time for a test (141, 143). Estimations of reliability can be carried 
out through analyses of internal consistency of a scale, through analyses of relationships 
between repeated measures (test-retest/stability), analyses of measurement errors (stemming 
from sources within as well as external to the individual), and analyses of similarities 
between raters/observers for non-self report assessments (141, 142). Based on CTT-
assumptions, information about reliability is sample-specific.  
1.7.3 Evaluating the validity of assessments  
Validity is defined as “the degree to which evidence and theory support the interpretations of 
test scores entailed by proposed use of tests” (p. 9, (141)). Validity is not a property of the 
test with distinct and fixed types – instead it is a process by which we continuously gather 
evidence for different aspects of validity (141). Validity refers to how well we measure what 
we intend to measure, in the specific setting and with the participants in question, and is 
therefore directly related to the strength of the conclusions of a study (142). For example, the 
interpretation of an assessment can differ between populations and study settings for many 
reasons (language comprehension, relevance of the construct, developmental aspects et 
cetera) (141), hence the evidence for validity of an assessment must always be reflected upon 
in order to determine if the conclusions from a particular study are valid (for example, if the 
results of a treatment evaluation can be attributed to an intervention, rather than other 
influences (internal validity), and if the results can be generalized to other settings or 
populations (external validity) (143). Empirical evidence for validity can be gathered through 
examinations of relationships between test content and the construct it aims to measure, 
through examinations of response processes, through examination of the internal structure of 
a scale (e.g. factor analysis to establish uni- or multidimensionality), and through examination 
of the test’s relationship to other variables, that is, with the underlying interpretation of 
constructs which can be predictive or concurrent in its nature, and the consequences of the 
testing (141, 142). Though there is “remarkable unreliability in use of the terms reliability 
and validity” (p. 358 in (143)), and some overlap between terms, a few specific definitions 
are worth noting: Construct validity, which refers to how well the assessment reflects the 
domain of interest; content validity, which concerns how the items relate to the concept 
behind the measure; criterion validity, which encompasses the correlation (concurrent or 
predictive) between the assessment and other relevant criteria; convergent and discriminant 
validity, which refers to how well the assessment is related to or different from other 
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assessments concerning similar or dissimilar constructs, and finally; face validity, which is 
not a formal type of validity but still important, as it refers to the experience of how well an 
assessments appears to measure what we are interested in (143) and thus might also be 
important in relation to the perceived relevance of an assessment for the participants. All 
these ways of gathering evidence for validity illustrate the iterative nature of the process. 
When using a test in a novel population; there is again a need for these reflections, analyses 
and investigations. Thus, without support for the validity of an assessment, we cannot be 
confident in our interpretation of data.  
1.8 Evaluating the state of evidence by conducting a systematic review and 
meta-analysis  
A systematic review (SR) aims to synthesize and evaluate empirical evidence for a particular 
research question, according to pre-determined criteria for inclusion, and can include 
evaluations of the validity of the studies included in the SR (144). A meta-analysis (MA) is 
often included in a SR, and refers to the statistical methods used to sum up the results from all 
the studies included in a SR (144, 145), i.e. that investigates the same phenomenon, to 
estimate the mean and variance of underlying population effects (146, 147). The quality of 
reporting in a SR is increased if the SR includes for example detailed reporting on protocol 
and registration, criteria for inclusion and exclusion of studies, a detailed description of the 
search strategy, selection and data collection, a clear synthesis, assessments of risks of bias 
both for individual studies and across studies, and more (148) - all of which serves to enhance 
replicability of the SR and evaluation of the validity of the findings. The Preferred Reporting 
Items for Systematic reviews and Meta-Analyses Check-lists (PRISMA), which includes a 
flowchart for the documentation of study identification, screening, assessment of eligibility 
and final number of studies included in the search and inclusion process, is an important 
guideline commonly adhered to by researchers conducting SRs (148). Quality ratings of 
included studies can be conducted using checklists like the Cochrane Collaboration Risk of 
Bias Tool for RCTs (144, 149) and the Quality Appraisal tool for non-randomized studies 
(150, 151). The methodological quality of the SR itself and thus the confidence in 
conclusions from the SR and MA can be evaluated by checklists such as the A MeaSurement 
Tool to Assess systematic Reviews (AMSTAR) (152, 153). The quality of evidence and 
strength of recommendations can be classified according to the Grading of Recommendations 
Assessment, Development and Evaluation (GRADE) system, which states how certain the 
estimate of effects found in an SR and MA is or, in other words, to which degree further 
research is likely to change the confidence in the estimate of effect (see e.g. (154)). Cochrane 
reviews, for instance, use GRADE to specify the level of quality for evidence from 
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randomized trials in their SRs and MAs (144). Studies are thereby examined in regard to 
methodological quality (design and risk of bias in the individual studies), if the evidence is 
direct or indirect (involving for example the generalizability of findings), the homogeneity or 
heterogeneity in results, if results are precise or imprecise (e.g. how wide the confidence 
intervals are) and finally, taking into account the risk of publication and selective reporting 
bias (144). The level of quality in the body of evidence is then rated as high, moderate, low or 
very low.  
In sum, SR and MA are used to synthesize current evidence and estimate population effects, 
and can help both health care professionals and patients to make informed decisions about 
health care. In pediatric chronic pain, the need for further development of effective 
interventions that address more than pain is evident. Findings from SR and MA are important 
tools for future research in this regard.  
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2 AIMS  
The purpose of this doctoral project was to develop effective ways to assess and treat 
dysfunction in pediatric chronic pain. The overall aims were to evaluate instruments assessing 
pain interference and insomnia, as well as the state of evidence for Intensive Interdisciplinary 
Pain Treatment, (IIPT), and the effects of Acceptance and Commitment Therapy (ACT) for 
this population. The specific aims in the respective studies are described below.  
2.1 Study I 
The study aims were: 1) To conduct a psychometric evaluation of a Swedish translation of 
the Insomnia Severity Index (ISI) in a sample of pediatric participants with chronic pain, 2) to 
assess the frequency and severity of insomnia in this sample, 3) examine the relationships 
between pain, insomnia, depression and functional disability and 4) explore the functional 
importance of insomnia in the relationship between pain and depression, and pain and 
disability.  
2.2 Study II 
The aim of study II was to evaluate the statistical properties of the Pain Interference Index 
(PII) in pediatric patients with chronic pain, including examinations of the factor structure of 
PII, concurrent criteria validity by examining the relationships between PII and pain intensity, 
depression and functional disability, and examinations of reliability by analyzing the internal 
consistency.  
2.3 Study III 
In study III, a systematic review and meta-analysis, the aims were to: 1) Describe the nature 
of IIPTs for pediatric chronic pain related to significant distress and disability, and to provide 
details on components in such treatments, and 2) to evaluate the effectiveness of IIPT post-
treatment and at follow-up by conducting a meta-analysis of 5 outcome domains: Pain 
intensity, disability, school functioning, anxiety, and depressive symptoms.  
2.4 Study IV 
The aims of study IV were to preliminarily evaluate: 1) The effects of an ACT-based 
intervention for adolescents with disabling chronic pain conditions on functioning (i.e. pain 
interference, pain reactivity, depressive symptoms and functional disability) pain intensity 
and psychological flexibility, 2) the effects of an ACT-based parental support program on 
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parent emotional functioning, pain reactivity and psychological flexibility, 3) differences 
between group and individual treatment formats, 4) temporal change patterns and 5) clinically 
significant changes.  
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3 METHODS 
The doctoral project includes several methodological approaches. Table 1 gives an overview 
of study design, data collection, participants, statistical analyses, and assessments used in 
each study respectively.  
3.1 Designs and settings  
As presented in Table 1, study I and II had a cross-sectional design, and psychometric 
evaluations were included in both these studies. Study III was a systematic review and meta-
analysis and study IV was a randomized non-controlled pilot trial.  
Study I, II and IV were conducted within a specialist pain treatment setting, the Functional 
Unit for Behavior Medicine Pain Treatment Services, Functional Area Medical Psychology, 
at Karolinska University Hospital in Stockholm, Sweden. All pediatric participants had been 
referred to the service due to chronic pain. Study III, a systematic review and meta-analysis, 
was an international collaboration with pediatric chronic pain researchers.  
3.2 Assessments for children and adolescents 
Assessments included in study I, II and IV are described below. See Table 1 for an overview 
of assessments in study I, II and IV respectively.  
3.2.1 Pain Intensity 
Current pain intensity was assessed by a numerical rating scale (NRS) (155) in two versions. 
In study I and II, pain was rated on a scale from 0 to 10, with 0 representing no pain and 10 
worst imaginable pain. The scale was administered at the time of first visit to the clinic, by a 
physician specialized in pediatric pain. In study IV, pain was assessed via self-report in 
conjunction with other questionnaires at all time points, on a scale from 0 to 6, with 0 
representing no pain, and 6 extreme pain. Though using 0-10 is recommended and most often 
used, the interval 0-6 is also common (156). Examination of the validity of NRS, by 
comparing the NRS with Visual Analogue Scales and Faces Pain Scale Revised support its 
use with children and adolescents (157) and there is also support for the convergent and 
discriminant validity of the NRS when used with children and adolescents who suffer from 
chronic pain (158).  
3.2.2 Insomnia 
Insomnia in children and adolescents was assessed with the Swedish translation of Insomnia 
Severity Index (ISI), adapted for youths (159). There is evidence for validity and reliability 
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for the ISI from many populations in different settings and languages translations (160-167). 
The ISI has shown sensitivity to change over time after treatment (159, 168) and can also be 
used for the purpose of screening insomnia problems (159, 168). ISI consists of 7 items 
relating to sleep problems experienced during the two weeks prior to assessment, including 
difficulty falling asleep, remaining asleep, and interference of sleep problem in daytime 
activities. The items are rated from 0 (not at all) to 4 (very much), and the maximum score is 
28. Before this doctoral project, only one study examining the validity and reliability of ISI in 
the pediatric population existed to our knowledge (161). In this Chinese version, ISI was 
found to correspond with other measures of insomnia, indicating concurrent validity, and 
criterion validity for the ISI was supported correlations between total scores and DSM-IV-TR 
diagnosis of clinical insomnia. Further, ISI showed an adequate internal consistency of 
Cronbach’s alpha=0.83 which supports the reliability of the ISI. A cut-off for clinically 
significant insomnia was set at 9 in that study (161).  
3.2.3 Depression 
Depression was assessed with the Center for Epidemiological Studies Depression Scale 
Children (CES-DC), in which the experiences, over the previous week, of 20 symptoms of 
depression are rated on a scale from 0 (not at all) to 3 (often) (169, 170). The maximum score 
is 60, and for adolescents, a cut-off score at 16 and above was suggested for discriminating 
major depressive disorder (171). In a Swedish study, examining the validity of the Swedish 
translation for adolescents, the cut-off was proposed to be 24 (172). In this study, the 
Cronbach’s alpha reliability coefficient was .91, and the validity of the CES-DC was 
supported by its correlation with another measure of depression, the Beck Depressive 
Inventory (172). CES-DC has also been used previously with pediatric participants with 
chronic pain (e.g. (52)), showing adequate internal consistency.  
3.2.4 Functional Disability 
Functional Disability in children and adolescents was assessed with the Functional Disability 
Inventory Parent version (FDI-P), where parents rate their child’s functional disability (173). 
In the FDI, daily activities such as walking, school attendance and peer activities are assessed 
on a scale from 0 (no problems) to 4 (impossible), and the maximum score is 60. It was 
originally developed to measure functioning in a broad spectrum of pediatric conditions, but 
has been used extensively with pediatric chronic pain populations and has shown evidence of 
reliability and validity as well as sensitivity to change after treatment (174). Its use has been 
extended to include Swedish adolescents as well (175), and the parent-version has shown 
good correspondence with child ratings (173, 176).  
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3.2.5 Psychological Inflexibility  
Psychological inflexibility in pain (i.e. the inability to behave in line with a valued life when 
pain, unpleasant thoughts or emotions are present) was assessed with the Psychological 
Inflexibility in Pain Scale (PIPS) (177, 178). PIPS include 12 items, which are rated on a 
scale from 1 (never true) to 7 (always true), and the maximum score is 84. Items concern the 
extent to which pain controls the participant’s life and valued activities, which often become 
limited through attempts to avoid pain and pain-related experiences. Research with adult 
chronic pain patients support the psychometric properties of the instrument as seen in for 
example adequate internal consistencies supporting its reliability, and strong relations with 
variables such a disability, and with other measures of acceptance and avoidance which 
supports the criterion and construct validity of the PIPS (178). Furthermore, PIPS has shown 
sensitivity to change after ACT-intervention (179). Preliminary analyses from the same 
sample as in study I and II has indicated the adequacy of PIPS for pediatric chronic pain, with 
results showing that PIPS explained a significant amount of variance in pain interference and 
depression, when controlling for pain intensity (180). PIPS has also shown excellent internal 
consistency, high correlations with the Chronic Pain Acceptance Questionnaire (CPAQ) 
which is a validated measure of acceptance (see e.g. (181)) and moderate correlations with 
depression as measured by the CES-DC. In addition, a preliminary Rasch-analysis with a 
subset of the sample in these preliminary analyses (n=75) indicated support for 
unidimensionality, precision and sensitivity, i.e. reliability of the PIPS (182).  
3.2.6 Pain Interference 
Pain Interference was assessed using the Swedish version of the Pain Interference Index (PII), 
also described in 1.3.2. Prior to this doctoral project, no thorough investigation of the 
psychometric properties in the Swedish version of PII had been conducted with pediatric 
participants. PII has shown sensitivity to change after treatment in pediatric participants with 
chronic pain (106). PII consists of six items, rated on a scale from 0 (not at all), to 6 
(completely), with a maximum score of 36. PII assesses the extent of pain impact on 
everyday functioning, including difficulties with school, leisure activities, spending time with 
peers, as well as effect on mood, physical activities, and sleep. In an English version of PII, 
Martin and colleagues (183) found evidence for concurrent criterion and construct validity, 
reliability and feasibility for both PII child report and parent-report, when used with youths 
suffering from medical conditions and co-morbid chronic pain (183). There is also support 
for the reliability and concurrent criterion validity of PII when used with adult patients with 
chronic pain (184).  
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3.2.7 Pain Reactivity 
Pain reactivity was assessed using the Pain Reactivity Scale (PRS) for children. The PRS 
measures worry and general emotional reactivity to pain (e.g. anger, sadness) (106), and 
includes five items rated on a scale from 0 (never/not at all), to 6 (always/very much). The 
maximum score is 30. Preliminary regression analyses (180) indicated that the PRS is 
important for explaining variance in pain interference and depression, when controlling for 
pain intensity. Also, PRS has shown sensitivity to change after treatment, and mediating 
effects on functional outcomes (106, 107). 
3.3 Assessments for parents  
3.3.1 Parent Pain Reactivity  
Pain reactivity was assessed by the Pain Reactivity Scale for parents (PRS-P) where parents 
rate their own reactivity to their child’s pain. See 3.2.7 for details.  
3.3.2 Parent Anxiety and Depression 
Parent anxiety and depression was assessed with the Hospital Anxiety and Depression Scale 
(HADS) (185). HADS consists of 14 items divided into two equal subscales, HADS-
depression and HADS-anxiety. Items are rated on a scale from 0 (most of the time) to 3 (not 
at al), and concern anxious and depressive symptoms. The maximum score is 42 (21, 
respectively, for the subscales). HADS is a well-established measure, which has been used in 
a wide variety of settings and populations, as shown in for example the literature review by 
Bjelland and colleagues (186). In this review, based on 747 studies using HADS, 71 papers 
including one conducted in a Swedish sample (187) were used for extracting information 
about the factor structure, internal consistency, relationship to other variables, and 
information about HADS as a case finder. Findings support the internal consistency, 
concurrent validity, and use of HADS both for assessing symptom severity and identifying 
cases from non-cases. Concerning cases, a cut-off of >8 on each subscale respectively, 
defines caseness (186). HADS has also been used previously with parents of adolescents with 
chronic pain. In the findings of Eccleston and colleagues (67), for example, HADS showed 
sensitivity to change after treatment.  
3.3.3 Parent Psychological Flexibility 
Parent psychological flexibility was assessed with the Parent Psychological Flexibility 
Questionnaire (PPFQ) (125). Support was found for both reliability and construct validity of 
this original scale, and results indicated its usefulness and importance for gaining information 
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about parental responses in relation to adolescent functioning. The original scale consisted of 
31 items, and further development of the instrument resulted in a 17-item version with 
support for reliability and criterion-related validity (188). In this doctoral project, a 10-item 
version of the PPFQ translated into Swedish was used, on the basis of a psychometric 
evaluation including factor analysis (n=263 parents of children and adolescents with chronic 
pain) (189). The maximum score of this version is 60, and items are rated on a scale from 0 
never true to 6 always true. Items include ratings of the degree to which, for example, valued 
activities are carried out despite the presence of child pain. The psychometric evaluation of 
the Swedish version indicated good internal consistency with alpha .86, a three-factor 
solution, and support for the concurrent criteria validity of the instrument (189). 
3.4 Statistical analyses 
An overview of statistical analyses included in each study is found in Table 1.  
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3.4.1 Correlation and regression analyses  
Correlational analyses were used to characterize the relationship between variables, for 
example by use of bivariate correlation analyses (Pearson’s correlation coefficient, or r) to 
assess the relationship between variables for examination of concurrent criteria-related 
validity (study I and II). Hierarchical regression analyses were used in study I and II, to 
predict values of the dependent variable (DV) on basis of one or more independent variables 
(IVs), thereby assessing how much each predictor variable contributes to predicting the 
outcome, or the amount of variance explained by predictor variables in the outcome variable 
(for example, in study I, the relevance of insomnia and pain intensity (IVs) for depression and 
functional disability (DVs)). Data was checked for assumptions before regression analyses 
were conducted, including degree of variance, multi-collinearity and correlations with 
variables not included in the analyses and sample size (190, 191).  
3.4.2 Factor analysis 
Factor analysis was used to determine whether the items in the assessment questionnaire PII 
reflected the same underlying variable, i.e. pain interference. Principal Component Analysis 
(PCA) is a standard procedure for evaluating the factor structure and can be used for reducing 
the number of items or variables to a smaller number (190, 191). PCA informs the researcher 
about patterns in the data, and combines variables into factors if they are correlated with each 
other but not with other subsets of variables (190, 191). When conducting a PCA, it is 
important to consider that it is sensitive to, among other things, the sizes of the correlations 
included, the sample size, missing data, and assumptions for normality and linearity (191). 
3.4.3 Analyses of internal consistency  
Analyses of internal consistency by use of Cronbach’s alpha were conducted to evaluate the 
reliability of assessments in study I, I and IV. Cronbach’s alpha takes into account both the 
variance within each item and the co-variance between every item in relation to all other 
items included in the assessment (190). It concerns interrelationships between items, and on 
the basis of this, indicates whether all items can be assumed to measure the same construct. 
High consistency indicates reliability of a measure (192). However, alpha is affected by the 
number of items in an assessment, with fewer items reducing alpha, and a large number of 
items increasing alpha (190, 192). Alpha is sample-specific, and therefore it is important to 
identify alpha for the scale for the specific sample in question in order to interpret data (192).  
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3.4.4 Analyses of indirect effects/mediation  
Analyses of mediation/indirect effects can be used for better understanding of how the effect 
from one variable on another operates (193). In study I, analyses of indirect effects were 
conducted to evaluate the mediating function of insomnia on the relationship between pain 
intensity and depression, as well as between pain intensity and disability. The model for these 
indirect/mediation effects (Figure 1) was based on previous longitudinal research suggesting 
sleep problems to be key for subsequent depression (40). Due to data being cross-sectional, 
many aspects of mediation are unavailable, such as evidence for temporal precedence (194). 
Significant indirect effects based on cross-sectional data are therefore insufficient to evaluate 
mediation, as time is a requirement for mediation to happen (195). To establish mediation 
according to Kazdin (196), a pattern of consistency should be seen, over a number of studies 
in which requirements such as strong associations, specificity, consistency, experimental 
manipulation, timeline, gradient and plausibility are addressed. Establishing indirect effects in 
cross-sectional data can provide a part of the argument for a possible mediator (193) and are 
thus informative e.g. to form hypotheses to be tested in longitudinal or experimental designs. 
In study I, the indirect effects were evaluated by means of the cross-product of coefficients 
(194) and the importance of the mediator (insomnia) was evaluated using both the Sobel test 
and a non-parametric bootstrapping method (197). 
Figure 1. The influence of insomnia on the relationship between pain intensity and 
depression, and pain intensity and functional disability.  
 
3.4.5 Tests of within and between group differences 
To evaluate differences within and between groups, both parametric and non-parametric 
analyses were performed: The Student’s t test, a parametric test of differences based on the 
normal distribution comparing means from two independent groups, and the Mann-Whitney 
U-test, a non-parametric test used to compare two independent conditions (190). Mann-
Whitney U-test was chosen for study IV because of non-normal distributions in several 
variables. Non-parametric tests such as the Mann-Whitney U-test make fewer assumptions 
  30 
about the data, and the test is based on a ranking-principle in which ranks are assigned to 
scores, with low ranks assigned to low scores and vice versa. In non-parametric tests, the 
median and range is used instead of the mean and standard deviation in the parametric 
counterparts (190). Mann-Whitney U tests were used for comparisons between group and 
individual treatment conditions, and between completers and non-completers in study IV, and 
t-tests were used for analyzing sex differences in study I and II.  
For non-parametric analyses of change between two related conditions in non-normal 
distributions, i.e. repeated measures data, the Wilcoxon signed rank’s test was chosen. In this 
test, differences are calculated, and then ranked as described above, but with the sign of 
difference assigned to the rank, i.e. the direction of the change (190). The Wilcoxon signed 
rank’s test was used in study IV for assessing when changes occurred, e.g. pre to post 
comparisons.  
3.4.6 Effect size calculations  
An effect size is useful for evaluating the importance of the findings in a study as it enhances 
interpretability and adds information beyond p-values, which can have limited practical 
meaning e.g. due to their sensitivity to sample size (198, 199). There are many different effect 
size statistics, but they all share the advantage of allowing comparisons between studies as 
they are independent of sample size (198). In study IV, effect sizes for non-parametric data 
were calculated from z scores and the number of total observations by use of r, which is a 
measure of the strength of an association (190, 198). Effects were considered small if above 
0.10, medium if above 0.30, and large if above 0.50, as proposed by Cohen (200). In study 
III, effect sizes were calculated by use of Cohen’s d, which is one approach for describing the 
standardized difference between means (190, 198). Importantly, effect sizes should be 
interpreted in the actual context (198), both with consideration of the design and procedure, 
such as the use of reliable measures, and the implications of the findings, such as costs for 
delivery, comparison with similar interventions, and sustained effects (198, 201). 
3.4.7 Analyses of clinically significant changes 
According to Kazdin (p. 332, in (202)) “clinical significance refers to the practical or 
applied value or importance of the effect of an intervention—that is, whether the intervention 
makes a real (e.g. genuine, palpable, practical, noticeable) difference in everyday life to the 
clients or to others with whom the clients interact”. There are many different approaches 
available for attempting to evaluate clinical significance, for example the proportion of 
participants who return to normal functioning (203). However, when criteria for determining 
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normal functioning are lacking, one alternative is to evaluate if the level of functioning after 
therapy falls outside the range of the dysfunctional population. In study IV, we calculated 
clinically significant changes using mean-based statistics, by the 1991 Jacobson and Truax 
approach (204), in which a change of two standard deviations (SD) from the mean of the 
population under investigation in the direction of better functioning is defined as a clinically 
significant change. Calculations of deterioration, with a change of two standard deviations in 
the direction of decreased functioning defined as clinically significant, were also conducted.  
3.4.8 Systematic review and meta-analysis 
The search strategy for the systematic review was developed in collaboration with an 
experienced librarian, and the search was based on the main terms Pain or Chronic pain, 
combined with terms that indicated interdisciplinary or multidisciplinary teams, in the context 
of children and adolescents. Search terms were grouped into three categories: intervention, 
target population and clinical condition. Six databases were searched electronically 
(Cochrane, Medline/PubMed, Psychinfo, Pubmed, PubPsych, and Web of Science), and 
databases were searched from inception to the 17th of February 2014.  
Two independent researchers screened abstracts for eligibility, and discrepancies were 
resolved through discussion with two additional independent researchers. Treatment 
evaluations with a RCT or non-randomized design were considered eligible. Studies were 
included if 1) the intervention coordinated by three or more different health professionals 2) 
treatment took place in an inpatient or day hospital setting 3) participants were aged <22 
years 4) participants had severe or disabling chronic pain 5) the study was published in 
English and 6) the study had >10 participants post-treatment. Included articles were read in 
full-text by three independent researchers, and evaluated by three additional independent 
researchers, with discrepancies again resolved through discussion.  
Meta-analysis, i.e. a statistical combination of results from included studies, was performed 
in study III to estimate the effect size at immediate post-treatment and short-term follow-up 
for all 5 outcomes: Pain intensity, disability, school functioning, anxiety and depression. 
Cohen´s d was computed for the changes between baseline and post-treatment, and baseline 
and short-term follow-up, with effect sizes of 0.2 defined as small, 0.5 defined as medium 
and 0.8 defined as large (200). Due to heterogeneity in the meta-analyses (144, 205), a 
random effects model was chosen on the basis of the assumption that the studies estimate 
different but still related effects from the intervention (144). The choice of a random effects 
model is also generally preferred in social sciences, on the basis of both the assumptions 
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about the population (variability in population parameters assumed) and the type of 
inferences the researcher wants to make (most commonly generalizations of findings beyond 
the studies included) (147).  
3.5 Description of the ACT-intervention 
At the tertiary pain clinic where study I, II and IV was conducted, the standard treatment was 
an ACT-based outpatient treatment, focusing on functional restoration, behavioral activation, 
and a functional approach to longstanding pain and symptoms. The clinic used an 
interdisciplinary approach involving psychologists, pain physicians and physiotherapists. 
Prior studies have evaluated this approach for both pediatric and adult patients (see e.g. (106, 
179, 206)). In study IV, some additions were made to the protocol compared with the 
protocol for the previous RCT with pediatric patients, such as the addition of a 
physiotherapist, additional involvement of the pain physician, and additional psychologist 
sessions for both parents and adolescents. This resulted in a total of 18 sessions, with one 
session conducted with both adolescent and parent present (continued pain education). 
Psychologists conducted a majority of the sessions. Four phases comprise the treatment, with 
slightly different objectives: 1) Preparing for behavior change (including educational 
components about longstanding pain, and about behavior analysis of antecedents, behaviors 
and short- and long term consequences), 2) Shifting perspective (from reduction of pain and 
related symptoms, to a valued life as defined by the patient), 3) Acceptance (that is, practice 
the willingness to experience pain, symptoms and related experiences without attempting to 
change them) and cognitive defusion (that is, noticing private events such as thoughts, 
feelings and bodily sensations and practicing perspective taking in relation to these events, 
thereby facilitating behaviors in favor of long term values and goals), and 4) Values oriented 
behavior activation (behavior change in service of a valued life). Consistent throughout all 
treatment phases is the emphasis on the function of behaviors, i.e. does the behavior serve 
avoidance of symptoms/aversive control or exposure to symptoms in the service of moving 
towards what is important in the long run/appetitive control. It is worth noting that, though 
acceptance and defusion were explicitly practiced in one of the phases, the emphasis on these 
alternate processes is interweaved throughout all phases of treatment. As this intervention 
was the standard treatment at the clinic, pediatric patients referred to the clinic but not 
involved in the study also received the same treatment, with minor individual adaptations. 
Details regarding the inclusion and exclusion criteria for study IV are given in 3.6 below. 
Participants were randomized to receive either individual or group treatment (for both 
adolescents and parents), with the same content in both contingencies, but with group 
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sessions being 2 hours instead of 45 minutes to allow for participation from all group 
members. Care was taken to ensure the age-appropriateness of metaphors and exercises. An 
overview of the intervention can be found in study IV (Table 1), and for a description in 
Swedish of this ACT-approach to chronic pain, see Wicksell (207).  
3.6 Participant-related ethical considerations 
Participants in the included studies were invited at the time of their first visit to the clinic 
(study I and II) or when meeting the team to decide about treatment (study IV). The local 
ethics committee had approved the studies (see below), and data collection primarily 
consisted of self-report questionnaires, with an additional and limited amount of information 
gathered as part of clinical interviews (e.g. pain characteristics). All participants and their 
accompanying parent received oral and written age-adapted information about the respective 
cross-sectional study (study I and II) or treatment evaluation (study IV), and both child and 
parent provided signed informed consent. Participants were informed that participation in the 
study was voluntary, and that refraining from participation or dropout would not affect their 
care at the clinic in any way, in line with the Declaration of Helsinki Ethical Principles (208). 
In study IV, standard treatment was offered if suitable to those participants who were not 
eligible, who declined participation, or who dropped out.  
3.6.1 Inclusion and exclusion criteria  
Participants eligible for inclusion in study I and II were consecutive patients, referred due to 
longstanding and/or recurrent pain, with a pain duration of at least 3 months). Inclusion 
criteria were a participant age of between 10 and 18 years for study I and between 7 and 18 
years for study II. Both study I and II required participants to have adequate Swedish 
language skills. In study IV, inclusion criteria were a participant age between 14-18 years 
(initially 12-18 years which was altered due to low inflow of younger patients), >6 months 
pain duration, little or no effect from previous pain treatments, and substantial pain disability 
detected in the assessment procedure. Exclusion criteria were 1) expected improvement 
without treatment (e.g. improvement between referral and assessment), 2) psychiatric co-
morbidity that was considered the main reason for disability, required immediate treatment or 
was assumed to interfere with treatment, 3) substantial risk for suicide, 4) substantial 
cognitive impairment or reduced proficiency in Swedish, 5) other on-going or planned 
treatments within the following 6 months, 6) pain was recurrent rather than continuous 
(defined as >4 pain free days per week), 7) pain fully explained by a pathological process e.g. 
cancer.  
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3.6.2 Risks and adverse events  
When planning the studies, we considered respondent burden, i.e. time and effort needed for 
participation (209), and questionnaire burden. All included assessments were considered 
relevant for participants, which is suggested to be a more relevant factor than the time it takes 
to complete them (210). In case distress would arise from items in the questionnaires, this 
could be addressed as part of subsequent clinical interviews, if needed.  
As described by Duggan and colleagues (211), adverse events from psychological 
interventions treatment are seldom reported, despite the risks that interventions can be 
associated with issues such as increases in symptoms or sustained deterioration. It is often 
difficult to establish how such harm has occurred – whether from the treatment, the 
application of the treatment, or factors that are related to the patient. The intervention in study 
IV involved exposure to previously avoided and possibly pain-provoking situations, in the 
presence of symptoms. Participants were therefore thoroughly informed about the treatment 
objective – living a valued life – and that this is can involve increased pain and associated 
distress. To evaluate possible adverse events from the intervention in study IV, clinically 
significant deterioration was therefore analyzed and reported.  
3.7 Research-related ethical considerations 
A number of steps can be taken to ensure both the quality of a study and research ethics 
throughout the process of planning of a study, conducting the analyses and report the 
outcomes (212). By using the Cochrane Collaboration Risk of Bias Tool (144, 149), possible 
sources of bias identified for study IV was the lack of blinding (in this case that the 
researchers were also involved in data collection, delivering the intervention, and analyzing 
the results), and the lack of pre-registration of the study (meaning that external examiners can 
not know if selective reporting has occurred). Steps taken to counteract bias was the use of a 
randomized sequence generation and allocation concealment, detailed reporting of reasons 
for attrition and exclusion after the start of the study, and the reporting of a broad range of 
outcomes, including non-significant findings. Another common problem in psychological 
intervention studies is power, with many studies being underpowered and thus more 
susceptible for bias (212). In study IV, a formal power analysis was conducted prior to the 
start of the study, based on the RCT (106), though this was only reported in the ethics 
approval and not in the article. Attrition subsequently led to the study being under-powered 
for the comparison between groups (individual and group treatment). In the article, this issue 
was clearly stated in relation to results. Furthermore, a conservative p value was chosen (p < 
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.01), and both effect sizes and analyzes of clinical significance were presented as the p-value 
in itself is not sufficient for justifying a scientific conclusion (213).  
For study III, a systematic review and meta-analysis, guidelines were followed to ensure 
study quality, including for example pre-registration of the study in PROSPERO, an 
international prospective register of systematic reviews with the aim of avoiding duplication 
and facilitate comparisons of the a completed review to its initial plan and thus reduce 
possible biases (214).  
3.8 Ethical permits  
For study I and II, ethical permits are 2009/470-31/3, and amendment: 2011/1734-32, and for 
study IV, the ethical permit is 2009/815-31/4. The PROSPERO-number for study III is 
CRD42014010719.  
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4 RESULTS  
4.1 Study I: Insomnia in pediatric chronic pain 
Participants in the study (n= 154) had a mean age of 14.6 years, and 75.3% were girls. There 
was a high prevalence of continuous or weekly pain (85.3%), and multiple pain locations 
were reported by a majority of the participants (75.8%). Furthermore, a majority also reported 
school absence due to pain (31% once a week or absent from PE, and 44% extensive or total 
absence, e.g. missing parts of school every day, or never attending school).  
ISI showed satisfactory psychometric properties in this sample, including support for 
reliability with an internal consistency of alpha 0.88, and item-total correlations between 0.41 
and 0.83, which corresponded to the original article by Bastien and colleagues (159). Support 
for concurrent criteria validity was gathered from significant bivariate correlations between 
ISI and CES-DC (depression) and FDI-P (functional disability) (r=0.32 – 0.50, p< .001).  
More than 50% of participants scored above 9 on the ISI, which has been suggested as cut-off 
for insomnia (161) and high ratings of depression were seen (CES-DC M=24).  
Hierarchical regression analyses showed that insomnia explained a significant amount of 
variance in depression: r2 change=18%, F change=33.67 (1,131), p< .001 and functional 
disability (r2 change=14%, F change=21.64, (1,125), p< .001) when controlling for 
demographic characteristics (age, sex, pain duration).  
Indirect effects of insomnia were found for both the relationship between pain and 
depression, and between pain and functional disability, with both the Sobel test and the 
bootstrap method being significant at p< .01.  
4.2 Study II: Pain interference in pediatric chronic pain 
Participants in study I and II were drawn from the same sample. In study II (n=163), the 
participants had a mean age of 14.1 years and 74.2% were girls. Continuous pain was 
reported by 55.8%, and daily episodes of pain by 22.7%, and the median pain duration was 
36 months.  
The psychometric evaluation of PII included item analysis, where response rates were 
excellent, and levels of skewness and kurtosis were satisfactory. The items also had adequate 
inter-correlations ranging between 0.32 and 0.69. Results from the PCA illustrated a 1-factor 
solution to be adequate for this instrument (eigenvalue >1), which accounts for 58.7% of the 
variance in this set of items.  
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Support for the reliability of PII in this sample was found in analyses of internal consistency, 
with Cronbach’s alpha=0.86. Concurrent criteria validity was supported by moderate 
correlations between PII and pain intensity, functional disability (FDI-P) and depression 
(CES-DC) (r=.381 – 0.691, p< .001).  
Hierarchical regression analyses illustrated the importance of PII in predicting levels of both 
FDI-P and CES-DC (p< .001) when controlling for age, and results were similar when 
controlling for pain intensity as well.  
4.3 Study III: IIPT for pediatric chronic pain 
The systematic searches resulted in 2577 abstracts, from which 65 articles met initial 
inclusion criteria and after reading of these, the final number of included studies were 10, 
with 1 RCT that compared IIPT to wait-list control group, and 9 uncontrolled prospective 
studies/non-randomized studies. The total number of participants was 1020, where the 
majority were girls, the mean age was 13.9 years, and mean duration of pain was 2.95 years. 
Characteristics for the IIPTs programs included a mean treatment duration of 16 days, 
psychological and physical interventions were reported in all 10 studies, and medical 
interventions in 9 studies. Parents were reported to be included in 8 studies. There was a 
range of treatment components included in the IIPTs. Only 3 studies reported details on pain 
medication during treatment for the participants.  
Quality ratings using the Cochrane Collaboration Risk of Bias Tool for the RCT (149) and 
the Quality Appraisal Tool for the non-randomized studies (150, 151) showed that all 10 
studies described the intervention and participant characteristics in a detailed manner. 
Consistent methodological limitations were observed, with the most protruding one being that 
only 1 study was an RCT.  
The meta-analysis provided preliminary evidence for positive treatment effects. Pooled 
estimates from the 9 non-randomized studies were presented separately from the results of the 
RCT. Effect sizes for the RCT were based on the intervention-group only, thus within-group 
analyses were conducted for both the RCT and the non-randomized studies. Large 
improvements at immediate post-treatment were observed for disability (large effect in the 
RCT, d= -0.80 in favor of IIPT) and across 6 non-randomized studies (d=-1.09), small 
improvements were observed for pain intensity (RCT significant effect d=-0.38, 4 non-
randomized studies small non-significant d= -0.32, and no or small effects for depression 
(RCT no effect, d= -0.22, 5 non-randomized studies small beneficial effect d= -0.37. The 
positive effects were maintained (disability) or further improved (pain intensity, depression) 
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at short-term follow-up. Due to substantial heterogeneity in measurements of anxiety and 
school functioning, effect sizes were calculated only, and not pooled. For anxiety, no effect 
was reported at post-treatment in the RCT, but for 4 non-randomized studies, effect sizes 
were large and ranged from -0.82 to -1.14. The positive effects remained at follow-up, and for 
the RCT, there was a positive large effect at follow-up (d= -1.02). For school functioning, the 
RCT and one non-randomized study had large effects post-treatment. At follow-up, the RCT 
and 4 non-randomized studies had moderate to large effect sizes (d=0.53 to -1.0).  
4.4 Study IV: ACT for adolescents with chronic pain and their parents 
A total of 48 adolescents were included in the study, and 30 completed post-assessments (24 
girls). There were no significant differences between completers and non-
completers/exclusions at pre for any of the variables included in further analyses, hence, 
analyses reported here are based on the final sample of completers (n=30 adolescents and 
n=28 parents). The mean age of participants was 16 years, and they reported a mean pain 
duration of more than 4 years. The majority reported continuous pain and multiple pain 
locations. Parents consisted of 28 parents (24 mothers), with a mean age of 47 years. Notably, 
57% of the parents reported a pain duration of 1 year or more.  
No significant differences were found between the individual treatment condition and the 
group treatment condition. Analyses illustrated significant (p< .01) improvements (medium 
to large effects) in pain interference, depression, pain reactivity and psychological flexibility 
post-treatment. Parent ratings of adolescent functional disability did not improve significantly 
p= .032). No significant changes were seen in adolescent pain intensity at any of the time 
points. Additionally, analyses showed significant (p< .01) improvements (large effects) in 
parent pain reactivity and psychological flexibility post-treatment. There were no significant 
changes reported in parent anxiety or depression. The pattern of results illustrated more 
significant changes from mid- to post, than from pre- to mid treatment.  
On all significant outcomes, clinically significant changes in the direction of functionality 
were observed for 21%–63% of the adolescents across the different outcome measures and in 
54%–76% of the parents. Deterioration was reported by 7% of participants regarding pain 
reactivity, and depression. In parent rated functional disability, 11% reported deterioration, 
and 4% reported deterioration in pain intensity. Of the 30 participants, deterioration in one or 
more of the variables above was reported by 5 participants in total.  
In addition to the results in the article, a complimentary analysis of the effects of treatment on 
sleep was conducted. Sleep was assessed in study IV as a secondary outcome variable. In the 
  39 
sample, median scores were above the suggested cut-off on ISI for clinically significant sleep 
problems (9, as found in (161)) at pre, and no significant changes were seen at either mid or 
post treatment (median pre=10.50, range 1-27, median mid=11.00, range 0-28, and median 
post=11.00, range 0-28, (p between .109 to .731).  
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5 DISCUSSION 
5.1 Assessment of pain-related dysfunction: Insomnia and pain interference  
This doctoral thesis contains two studies aimed at the development of reliable and valid 
measures of pain-related dysfunction, specifically insomnia and pain interference.  
The findings from study I include support for the internal consistency and concurrent criteria 
validity of the Swedish translation of the ISI used in a sample of pediatric patients with 
chronic pain. The ISI is already a well-know measure of insomnia in adults, used world wide 
(152-159), including a recent study evaluating the psychometric properties of the ISI in a 
sample of Swedish adults with chronic pain (166). Our findings suggest that insomnia can 
also be adequately assessed in the pediatric chronic pain population, for which measures of 
insomnia have been lacking. A systematic review from 2011 (133), found no measure of 
insomnia that had been evaluated for adolescents and, to our knowledge, the only study that 
existed in this regard prior to this doctoral project was the Chinese evaluation of ISI for 
adolescents (161). Thus, the results from our study are relevant for a range of pediatric health 
care services where insomnia should be assessed and treated, in line with recent suggestions 
(43, 44).  
Our findings replicate and extend prior studies showing insomnia to be prevalent in pediatric 
chronic pain. In a cross-sectional study by Palermo and colleagues (52), where insomnia 
symptoms were assessed using only 2 questions (difficulties falling asleep and staying 
asleep), 54% of youths with chronic pain reported one of these difficulties as compared to 
20% in the comparison group. In our study, using the ISI, 52% of the participants scored 
above the cut-off for insomnia suggested in previous research with adolescents (161). We 
found insomnia to be highly important in explaining depression and functional disability in 
pediatric chronic pain, more so than pain intensity. This is also in line with the findings in the 
study by Palermo and colleagues (52), who noted that presence of chronic pain rather than 
levels of pain intensity, was more important in regression analyses with insomnia symptoms 
as the outcome. Similar findings were seen in a longitudinal study by Palermo and colleagues 
(56), with behavioral factors rather than pain intensity predicting insomnia over time, and 
presence of insomnia being related to lower health related quality of life and higher use of 
medical services. Further, our results suggest that insomnia strongly influences the 
relationship between pain and functioning. Thus, targeting insomnia directly in treatment 
appears to be important. Insomnia of pain related origin might spiral into a primary problem 
of its own (as discussed by Palermo and colleagues). Given the prevalence of sleep problems 
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in adolescent populations (37), insomnia might also have been present before the onset of 
pain, and serve as an exacerbating factor. Regardless of direction, insomnia appears highly 
relevant for functional outcomes and as seen in the longitudinal study by Palermo and 
colleagues (56), insomnia symptoms persisted over time for both the chronic pain group and 
the healthy control group. This indicates the need to address insomnia in adolescents both 
with and without co-morbid medical conditions. More research is needed to confirm whether 
insomnia is a “candidate mediator” (p. 17 in (196)) which mediates functional outcomes in 
pediatric chronic pain, for example RCTs in which a sleep intervention targeting insomnia or 
other sleep problems is given as an add-on to one of two treatment groups receiving a 
behavioral pain management intervention like the one in study IV or those described in study 
III, and where insomnia symptoms are assessed parallel to other potential mediators, in both 
groups repeatedly during treatment.  
The findings from study II include support for the factor structure, internal consistency and 
concurrent criteria validity of this Swedish version of the PII when used in a pediatric chronic 
pain sample. Items in PII are likely to reflect the same underlying dimension of pain 
interference, as indicated by factor analysis. Our results point to the utility of the construct of 
pain interference for pediatric chronic pain, and for using the PII when assessing pain 
interference in this population. Importantly, PII has also been evaluated in an English version 
with pediatric participants suffering from chronic illness and pain, and support was found for 
the reliability and validity of both child and parent-report (183). Further, both the child 
version and the parent version of PII have shown sensitivity to change after ACT-based 
behavioral treatment interventions (106, 127, 215). These findings, together with the brevity 
of the instrument and the ease with which instructions and items can be understood, support 
further use of PII both for repeated assessments during treatment, and as a measure of 
treatment outcome.  
A moderate correlation between PII and the FDI-P indicates concurrent criteria validity. The 
fact that the association appears to be moderate, and not strong, indicates the difference 
between pain interference and the physical functioning domain, in turn highlighting the 
importance that both factors are addressed in treatment. This has also been put forth in a 
study of adult pain interference and physical functioning (60). Our research group has 
examined the indirect effects of pain interference as measured by PII on the relationship 
between pain intensity and physical and emotional functioning (assessed with the FDI-P and 
CES-DC) in the same sample as study I and II (216). Results showed significant effects of 
pain interference on both these outcomes, and directionality was indicated by the absence of 
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effects when depression and functional disability were tested as mediators for the relationship 
between pain intensity and pain interference.  
The other available instrument for assessing pain interference in children and adolescents 
with chronic pain, PROMIS-PI (62), which has been developed using Item Response Theory 
(IRT) has recently been evaluated in a clinical sample with results indicating validity and 
responsiveness. The PROMIS is a large-scale initiative aimed at developing PROs for 
chronic disease in general. Through IRT-analyses, item banks are created for different 
disorders, and computerized adaptive tests can then be used which selects items based on an 
individuals response to previous items (62, 66). Implementation of the PROMIS system 
would be an important addition for pediatric chronic pain research as well as for clinical 
purposes in Sweden, and PII could serve as a useful legacy scale for evaluation and 
subsequent implementation of the PROMIS-PI, which has not yet been evaluated in Swedish.  
A final important note concerning PII and ISI is that there is now support for their validity 
and reliability in both pediatric and adult samples that suffer from chronic pain. The need for 
studies with a developmental focus that follow late adolescents with chronic pain into young 
adulthood, has been put forth (217), and by using the PII and the ISI, it is possible to 
investigate insomnia and pain interference longitudinally in this important period of life.  
5.2 Effects of IIPT and ACT outpatient treatment 
Two different studies were conducted to examine the utility of behavior-oriented treatments 
for pediatric chronic pain.  
The systematic review included 10 studies evaluating IIPTs for pediatric chronic pain 
associated with severe distress and disability. Characteristics of included studies showed 
similarities regarding participants and treatment programs, but less consistency regarding 
assessments of relevant outcome domains, and lack of details around the dose of different 
interventions included in the programs.  
The meta-analysis provided preliminary evidence for positive treatment effects of IIPT. Large 
effect sizes were seen for important outcomes, for example disability, and beneficial effects 
were maintained or further improved at short-term follow up. Notably, only one study was a 
RCT. This lack of rigorous methodology in the vast majority of included studies prevents 
causal conclusions, as findings can be attributed to other factors than the treatment per se (e.g. 
consumer satisfaction, or factors unrelated to treatment). There is a great need for more 
studies investigating the effects of IIPT by RCT design.  
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There was substantial heterogeneity in outcomes included in the meta-analysis. Heterogeneity 
in studies can result from clinical diversity such as differences in the participants or outcomes 
examined, from statistical heterogeneity caused by methodological diversity, or both, but it is 
commonly difficult to establish to which degree heterogeneity results from one, the other or 
both sources (144). Different strategies can be used to deal with heterogeneity. One option is 
a random effects model for analyses, as used in this study. Alternative strategies include 
refraining from meta-analysis, exploring subgroups of studies, or changing the effect measure 
(144). The small number of studies prevented options that use sub-group analyses to explore 
heterogeneity. Further, for the outcomes for anxiety and school functioning, the measures 
used were too dissimilar, and meta-analysis was not conducted. 
In addition to conducting studies with higher methodological quality, there is a need to 
conduct studies that promote further developments of IIPTs, for example providing detailed 
descriptions of treatment content and dose of components/interventions delivered by the 
respective disciplines included in the IIPT, and using randomization of included components 
to examine their effects. Further, intensive data collections with multiple assessment points, 
for example using real time data collections (218) could be used to examine in more detail at 
what point changes occur, and in relation to which interventions and contextual factors. 
Finally, coherence in outcome measures for physical, social and emotional domains, and the 
inclusion of assessments of pain medication and health-care costs to a larger extent in future 
evaluations of IIPTs would provide important information for professionals and patients 
alike. 
The pilot trial of ACT supports previous findings, as increased functional outcomes were 
seen post treatment, which provides further promise for the utility of ACT in this population. 
Despite the brevity of the protocol, and the severity of pain-related dysfunction in the sample, 
statistically as well as clinically significant improvements were seen in a range of adolescent 
outcomes. The study also provided novel findings concerning outcomes for parents after 
participating in a parent support program in conjunction with their child’s treatment. Parent 
psychological flexibility has been put forth as a potentially important treatment target in 
interventions for pediatric chronic pain (125, 188) and this issue was explicitly targeted in 
parent sessions. Although the parent support program only consisted of 4 sessions in total, 
significant reductions in parent pain reactivity and improvements in parent psychological 
flexibility were reported post-treatment. This promising result paves the way for further 
research into parent support based on ACT.  
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Preliminary comparisons of group and individual treatment formats were conducted, and 
similar results were found for both formats. Thus, from a resource allocation perspective the 
study provides preliminary support for utilizing a group format if no clinical factor clearly 
calls for individual treatment. A future methodologically rigor noninferiority trial including a 
larger sample and a pre-specified noninferiority margin for the primary outcomes (219) could 
provide further information regarding our preliminary finding indicating that group 
interventions may be as effective as individual interventions.  
The results from our preliminary evaluation of temporal change patterns suggest that effects 
may occur in the later phase, indicating the need for studies examining treatment components, 
and studies that explore trajectories of change, in line with the study by Palermo and 
colleagues (220), where some patients reported improvements, and others reported worsening 
or minimal improvements in pain and function during the 8-10 week treatment period. Our 
preliminary findings could imply that some individuals that do not respond quickly may yet 
be benefitting from the treatment. This could also imply the relevance of further exploring the 
temporal dimension, since a subgroup of patients may illustrate continuous improvements 
over time and benefit from a more extensive treatment program. However, there is a need for 
more information regarding predictors and moderators of change, and how treatment can be 
adapted on the basis of such findings. Some examples of factors that have been suggested to 
be of importance for treatment outcomes include anxiety, willingness to self-manage pain, 
parent distress and behaviors, and acceptance and psychological flexibility. Cunningham and 
colleagues compared children with chronic pain who had clinical versus subclinical levels of 
anxiety, and found clinical levels of anxiety to be associated with poorer treatment response 
in pain intensity and functional disability after CBT-treatment (221). Logan and colleagues 
found that willingness to self-manage pain increased during interdisciplinary treatment, for 
both children and parents, and that child willingness was associated with outcomes such as 
depression and functional disability, indicating that readiness to change is a potential 
mechanism of change in treatment and predictor of treatment response (222). Findings from 
two studies on longitudinal associations between child and parent functioning have been 
discussed in 1.3.4 and 1.6.1, with one study showing parent avoidance and protective 
behaviors to predict child depression and school functioning post treatment (74), and the 
other study showing that higher parent distress predicted less improvement in child disability 
over one year (124). Further, as noted in 1.6.2, changes in parent psychological flexibility 
was significantly related to changes in adolescent pain acceptance (129). Finally, as discussed 
in 1.4.2, the association between child acceptance and sustained changes in outcome (108), as 
well as the mediating role of psychological flexibility for treatment outcomes has been shown 
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(106). Thus, building on promising initial findings such as these, future studies examining 
predictors, moderators and mechanisms of change can be conducted to increase our 
knowledge on how to improve child and parent outcomes.  
In study IV, clinically significant improvements were seen to a large extent for both 
adolescent and parent outcomes, indicating that the treatment had a multi-dimensional 
practical impact for many participants. However, some participants did not report such 
changes, and a small subset of adolescents even reported clinically significant deterioration. 
This finding serves as a further reminder of the importance to investigate predictors and 
moderators of treatment outcome, as well as ways in which to tailor treatment for particular 
subgroups of patients. In addition, what constitutes a clinically significant change in 
functioning outcomes for pediatric chronic pain patients should be investigated further, and 
with other approaches. As described by Kazdin (202), several considerations should be taken 
into account when evaluating clinically significant changes, from the meaning and 
interpretation of the measure, to how the assessment relates to the goal of the therapy, and the 
constructs reflected. For pain intensity, analyses have been made to assess minimally 
clinically significant differences for pain intensity (see e.g. (223)), and for the FDI, clinical 
reference points have been suggested for what constitutes different degrees of disability 
(174), which enhances both the clinical and the research utility for the FDI as an outcome 
measure. Similar steps should be taken for assessments concerning other important treatment 
outcomes, such as the PII and the PROMIS pain interference scale (66).  
As seen in Table 2, findings from the systematic review on IIPT and from the pilot study of 
ACT show both similarities and differences. The IIPT has a greater focus on physical 
rehabilitation, which is also reflected in physical functioning outcomes. This indicates that 
this particular treatment format may be important for participants with severe physical 
dysfunction. Both IIPT and outpatient ACT resulted in preliminary positive treatment effects 
for depression. The co-morbidity of chronic pain and mental health problems is well known, 
and emotional outcomes constitute important treatment targets (25). Adolescents in study IV 
as well as in the bigger sample in study I and II presented with high scores of depression, 
indicating the presence of severe emotional dysfunction in this sample (median score for 
CES-DC at pre in study IV was 28, and in study I the mean was 24.20, as compared to the 
mean score of 13.2 for CES-DC in a Swedish general adolescent population (172), and to a 
clinical sample of adolescents with chronic pain where the mean for CES-DC was 14.22 (52). 
When analyzing ratings of depression in study IV, we found a medium effect size for the 
improvements pre- to post, and clinically significant improvements in 39% of participants. 
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Similarly, the effects from IIPT showed a small beneficial effect on depression at post and 
follow-up for the non-randomized studies, and a moderate effect for the RCT at follow up. 
These are particularly relevant findings, as reports of improvements in depression after CBT 
for pediatric chronic pain have been lacking (88). 
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5.3 Clinical implications 
Almost 10 years has passed since the PEDIMPPACT recommendations were issued (132), 
stating the need for development of reliable and valid assessment of pain-related dysfunction, 
such as functional impairment and sleep outcomes, specifically for pediatric patients with 
chronic pain. In this statement, authors encouraged both the evaluation of adaptations of 
existing well-known existing measures to the pediatric chronic pain population, as well as the 
development of new measures particularly for this group. The studies included in this thesis 
provide support for two instruments of relevance for the assessment of pain-related 
dysfunction. Both the PII and the ISI are brief instruments that are easy to administer and 
complete, which also makes them good candidates for repeated assessments and for use with 
digital tools. They have a clear clinical utility as they assess domains that can be targeted in 
treatment.  
Behavior-oriented multidisciplinary treatment programs based on CBT and ACT, delivered in 
intensive residential or day hospital settings or as outpatient interventions in group or 
individual format are promising for improving a range of functional outcomes in pediatric 
patients with chronic pain. To confirm and extend these findings, there is a need for studies 
with a more rigorous design, control-conditions, and with larger samples, as well as 
investigations of mechanisms of change and their relation to the theoretical foundations of the 
treatments. Such information is crucial in order to establish which type of treatment program 
and/or format, which is best suited for particular patient profiles.  
The high prevalence of insomnia indicates the need to address sleep difficulties as part of 
treatment. Similar to our findings from the additional analyses of insomnia in study IV, other 
treatment evaluations have also reported an absence of changes in sleep outcomes after CBT-
treatment for pediatric chronic pain (134, 224). However, in an intensive interdisciplinary 
treatment evaluation by Logan and colleagues, sleep habits improved, and were of 
importance for post-treatment reductions in pain intensity for adolescents with chronic pain 
(225). It has been hypothesized that sleep problems in pediatric chronic pain might have other 
explanations than pain in itself and that an increased focus on assessing and treating specific 
sleep problems such as insomnia, but also sleep times, sleep quality and quantity, in pediatric 
chronic pain as well as pediatric primary care in general, is needed (43, 224).  
The preliminary findings from the evaluation of parent outcomes after the brief ACT-based 
parental support program are promising. Parents of children with pediatric chronic pain often 
struggle with their own distress related to their child’s condition, and commonly also report 
own chronic pain (119, 120). Thus, parental distress as well as parent mental health need to 
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be addressed in order to facilitate effective parent behaviors. The findings from study IV 
together with similar findings from recent studies indicate that parent psychological 
flexibility can be targeted successfully in treatment (128, 129).  
5.4 Limitations 
In the psychometric evaluation of ISI and PII, limitations include the lack of child reported 
functional disability as only the FDI-parent version was used. Similarly, an additional 
measure of sleep, either a validated self-report questionnaire or actigraphic assessment would 
have been beneficial for additional information regarding validity in the psychometric 
evaluation of the ISI.  
The non-randomized study design of 9 of the 10 studies included in study III limits our 
confidence in the conclusions from the meta-analysis. When studies included in a MA have a 
non-experimental study design, this prevents causal conclusions (146) and highlights the need 
for future RCTs.  
A potential limitation concerning the search strategy in study III is that searches were 
conducted exclusively in databases, which is related to a risk for file-drawer 
effects/publication bias (147). However, unpublished material can lack detailed reporting, 
which limits possibilities for quality assessment, and the process of finding unpublished 
material can be difficult to replicate (226).  
Similar limitations as identified for studies concerning ACT-interventions in pediatric 
populations (98, 99) also hold true for study IV. There was no control group for adolescents 
or parents, which limits the certainty about main treatment effects. Improvement might thus 
be a result of unspecific factors, not related to treatment. Further, the sample is relatively 
small, and the design did not allow for examination of change processes. As follow-up 
assessments were not included, analyses of the stability of treatment effects were prevented. 
This lack of follow-up assessments also prevented further analyses of deterioration over time. 
Concerning the comparison between treatment formats, there were some unexpected 
difficulties as a few participants declined participation after being randomized to group 
treatment. Logistical reasons including inflow of participants and changes in staff brought the 
study to an end before the desired number of participants was achieved. Finally, information 
regarding medication for the sample would have provided important information. As many 
children with chronic pain are medicated despite lack of indication for pharmacological 
treatment (84), and few studies have properly addressed and evaluated the incremental utility 
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of medications in treatment programs for pediatric chronic pain (as noted in study III), this is 
an important addition for future studies.  
5.5  Future research 
Current prevalence rates and availability of evidence-based treatments clearly suggest the 
need to increase access to effective therapies for pediatric patients with chronic pain. New 
technology is already in place using internet-based solutions (123, 227), which reduces 
geographical barriers to care, and facilitates multi-center studies/studies with a national or 
international uptake and thus a large sample size. Such initiatives could be used for large-
scale analyses of predictors and moderators of treatment effects, and identification of sub-
groups of patients, for example those who have the highest co-morbidity or most severe 
dysfunction, or the group associated with the most extensive health care costs (as seen in the 
study by Groenewald and colleagues (75)), and provide more information about health 
service and medication use (76) in relation to treatment outcomes. Further, the utilization of 
more intensive data-collections through computerized measures enables thorough analyses of 
change processes.  
Consensus around process and outcome measures is needed in order to pool data. Recent 
advances in assessment development suggest it might be time for updated PedIMMPACT 
recommendations.  
Qualitative investigations of patient experiences related to both successful and unsuccessful 
treatment outcomes can shed light on mechanisms of change and if theoretical assumptions 
supported from adult research also holds true in pediatric populations. Qualitative 
methodology will also be important in future development of assessments, and in evaluations 
of what constitutes clinically significant changes for a developing individual (202, 217). By 
focusing on engaging the patient in both the health care service and the research agenda, i.e. 
patient-public-involvement (PPI), the unique experience of the child and adolescent should be 
taken into account (228). This could advance clinical routines and research questions, and 
information could be gained about possible improvements to interventions for particular 
subgroups of patients, patient satisfaction, and adverse treatment events, which have been 
called for in treatment of pediatric chronic pain (118, 229).  
Finally, given the high prevalence of chronic pain in pediatric populations and the co-
morbidity with mental health disorders and family disturbances, preventative efforts are 
needed on a large scale for young people and families, promoting healthy emotional, social 
and physical functioning from an early age and beyond.
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6 CONCLUSIONS 
Pain interference and insomnia are important factors for pain-related dysfunction in pediatric 
chronic pain and can be adequately assessed using the PII and the ISI. In the treatment of 
pediatric pain-related dysfunction, IIPT is promising although more and larger well-designed 
studies are needed. Also, a relatively brief outpatient ACT program may be used to improve 
functioning in pediatric chronic pain, delivered as individual or group treatment. 
Furthermore, results indicate preliminary evidence for the utility of ACT based parent 
support, in improving parent emotional reactivity and psychological flexibility, in the context 
of pediatric chronic pain. The results from the studies included in the present thesis can 
contribute to improved assessment and treatment of this complex condition, and warrant 
more research on how to improve child and parent outcomes. Future studies should utilize 
both rigorous methodology and frequent data collections to increase our knowledge about 
outcomes as well as change processes, and advance our understanding of how to help those 
who experience pain-related dysfunction in the presence of pediatric chronic pain.
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